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In modern day medicine medical images are an integral part of clinical care. They are used in 
almost every clinical department from diagnosis to treatment and beyond. Medical images are 
viewed using electronic displays of various sizes, shapes, hardware, and software. Some clinical 
departments, like diagnostic radiology, require electronic displays with a large dynamic range, 
high contrast and high resolution. Other departments do not have any requirements and will use 
any commercially available display in their clinical workflow.  
 
Viewing the same medical image on different electronic displays with different hardware, 
software or calibration setup could influence how observers perceive and analyze these images. 
This occurs often when a patient is referred from diagnostic radiology to another clinical 
specialty department such as radiation oncology. In this case, the patient’s tumor would be 
diagnosed using a high-performance display while their treatment will be planned and delivered 
using a commercially available display.  
 
In this dissertation, at first, an experiment was design to examine and verify the visual contrast 
sensitivity of observers using the two types of displays used in the clinic. Observers were tasked 
with detecting a modulating bar pattern using each display under different background luminance 
levels and ambient room illumination. The luminance response of each display was also 
measured for proper comparison. Second, a set of visual experiments compared the image 
quality of both displays in the different sections of the radiation oncology workflow. Observers 
were tasked with comparing medical images viewed on both displays and ranking them on a 
rating scale. As part of the workflow, the observers used both displays to contour tumor and 
healthy tissue volumes, analyze and fuse two sets of images, verify and adjust patient’s treatment 
position in three degrees of motion.   
 
The results show a clear presence for the high-performance display over the commercial grade 
display in every step of the radiation oncology workflow. It was shown that better visualization 
of medical images can improve the accuracy and precision of treatment plan and treatment 
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Medical imaging has evolved tremendously in the past century. In 1895 Wilhelm Röntgen took 
the first medical image of his wife’s hand. It was the first-time humans could see inside the body 
without cutting it open. The technology quickly spread and was used extensively in World War I 
to diagnose injured soldiers [Scatiff and Morris, 2014]. Over the next seventy years medical 
imaging advanced with the introduction of intensifying screens, hot-cathode x-ray tubes, rotating 
anodes, image intensifiers and contrast agents. Even though hard copy film was the only way to 
view an image, it still had limitations. Film had a limited linear response to radiation; it could not 
tolerate a wide range of radiation exposure without saturating which resulted in a short dynamic 
range. This caused some areas to be overexposed and some under exposed in the same film. 
Also, the image could not be adjusted once it was taken and it would take a long time to develop. 
In addition, film required additional technology to view, archive and transmit to others.  
 
The need for a better image management and processing pushed for the establishment of a 
picture archiving and communications systems (PACS), and the move to digital imaging began. 
Today instead of viewing medical images on film, they are viewed using an electronic display. 
Display technology had to continue and evolve to match and surpass the level of contrast and 
resolution film had to offer.  
 
Medical images became an essential part of modern-day medicine. They are used to diagnose 
patients with various illnesses or injuries and assist with planning a course of treatment or 
assessing its progress. In most clinical environments, medical images are viewed on electronic 
displays of varying types, sizes, setup and calibration. According to the American College of 
Radiology (ACR) [American College of Radiology, 2017] these displays can be separated into 
two different categories: 
• Diagnostic (primary) displays are used for primary interpretation of a medical image.  
• Non-diagnostic (secondary) displays are used for everything else.  
2 
 
The American Association of Physicists in Medicine (AAPM) created several task groups (18, 
270) to produce guidelines in assessing the performance of electronic displays that are used 
clinically. The task groups published guidelines for the testing and maintenance of various 
electronic displays used in medicine [Samei et al., 2005; Bevins et al., 2019].  
 
One of the clinical departments that heavily relay on medical images is radiation oncology. 
Medical images are used in each step of the clinical workflow. First, the treatment planning 
phase utilizes medical images to create a radiation plan and contour the tumor volume and the 
healthy surrounding tissue. Next, the treatment delivery phase utilizes medical images to 
properly align the patient to the planned treatment position. The quality of the treatment plan 
depends, in parts, on the proper visualization of medical images. When a patient is first 
diagnosed, their medical images are interpreted using a display with features that are design to 
maximize their quality. Therefore, theoretically such a display can be used in the treatment of 
disease as well. A better visualization tool, like a better display, could affect the way a treatment 




In this dissertation electronic displays with different image quality features are evaluated within 
the radiation oncology workflow. The evaluation consisted of comparing a display with higher 
image quality capabilities with a display that is currently used in the workflow.  
 
First, both displays were characterized by measuring their luminance response and comparing 
both to a commonly used medical imaging standard (the DICOM standard). Then, the contrast 
sensitivity of observers was measured using a modulating bar pattern target under different 
viewing conditions using both displays.  
 
The clinical performance of both displays was also compared using a set of image quality 
comparisons. Observers were asked to assess the image quality of medical images viewed on 
both displays and rank them on a rating scale. The image comparison was done in three clinical 
phases, treatment planning, treatment delivery and special procedures. The results of this 
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research showed how a display with superior image quality features improved the accuracy and 





There has not been any research on the detectability and visualization of medical images using 
electronic displays in radiation oncology. This research is the first attempt in evaluating a 
diagnostic (high-performance) display in such setting. In this research, three novel contributions 
are presented: 
• Optimization of viewing conditions for electronic displays in radiation oncology. 
• Evaluation of display image quality with respect to treatment planning. 
• Evaluation of display image quality with respect to treatment delivery. 
 
The contrast sensitivity of observers was measured using a target with modulating bar patterns 
using three different backgrounds (white, middle gray and black) under three different ambient 
illumination (bright, dim and dark) viewed on a high-performance and conventional displays. 
This will allow users to optimize the detectability of medical images using electronic displays as 
explained in this dissertation.  
 
The image quality comparison experiments between the two displays provided clear evidence of 
the advantage a high-performance display might have in a radiation oncology workflow. Results 
provide insight on the difference in visualization of critical organs and tumor volume, 









1.4 Dissertation Structure 
 
Chapter 2 reviews past studies on display technology and medical imaging. This review includes 
the various types of displays used, the development of the DICOM standard and the gray scale 
display function (GSDF part 14). In addition, the contrast sensitivity of the human visual system 
and the use of images in radiation oncology is also reviewed.  
 
Chapter 3 discusses the results from the contrast sensitivity experiments. The first experiment 
involves measuring the luminance response of each display as well as a comparison to a 
calibrated standard. The second experiment involves measuring the contrast sensitivity of 
observers to a modulating bar pattern target under different viewing conditions. The design of 
the target and experimental setup are explained. The results are presented and discussed.  
 
Chapter 4 discusses the results from the clinical image quality comparison experiments. The first 
experiment involves a comparison with respect to the treatment planning phase. The results of 
the measurements are provided and discussed. The second experiment involves a comparison 
with respect to the treatment delivery phase. The results of the measurements are provided and 
discussed. The last experiment involves a comparison with respect to radiation oncology special 
procedures. The results of the measurements are provided and discussed.  
 













2 Display Technology and Medical Imaging 
 
This chapter reviews past studies related to display technology, contrast threshold and medical 
imaging. 
 
2.1 Display Technology 
 
2.1.1 Cathode-Ray Tube (CRT) 
 
Since their introduction, electronic displays have been studied extensively to improve their 
clinical role. These studies have mostly focused in the field of diagnostic radiology as it was the 
main driving force for the introduction, and continued evolution of displays in medicine. In the 
early days of digital imaging, the most common method of viewing medical images was hard 
copy film. Images would be taken using film and later digitized for electronic visualization and 
archive. In order to validate electronic displays for diagnostic use, studies began to compare 
images on film with images on the most advanced display at the time, a cathode-ray tube (CRT) 
display. A CRT display produces an image when its phosphorescent surface is struck by 
electrons emitted from the cathode and accelerated through the tube. Monochrome CRT display 
will have one electron gun while a color display will have three (red, green and blue). 
 
 




Cook et al. compared a CRT display with film using a set of computed radiographic images. 
They have concluded that both modalities provided equal detectability, but the CRT display 
performed poorly when inappropriate window/level settings were chosen (the window setting 
determines the range of pixel values and the level setting determines the middle grey pixel 
value). They also concluded that CRT displays can decay over time and require constant 
adjustments and calibration [Cook et al., 1997].  
 
Seeley et al. comparted a fluorescein angiography film with a CRT display and the effectiveness 
of information transfer to an ophthalmologist. Their results show no difference in diagnostic 
accuracy between the two modalities. They concluded that a CRT could deliver the needed 
diagnostic information as well as film. They also hypothesize that digital enhancement 
techniques would increase the available information beyond that of film [Seeley et al., 1989]  
 
2.1.2 Liquid Crystal Display (LCD) 
 
Electronic display technology continued to evolve with the creation of a flat panel display 
utilizing liquid crystal display (LCD) technology. LCDs utilize an array of light emitting diodes 
(LED) behind the panel that acts as the light source. LCDs use liquid crystals inside each pixel to 
control the light intensity of each basic color. The light then passes through a color filter that 
filters out all wavelengths except red green or blue. Comparted with a CRT display, LCDs are 
much lighter and thinner yet still maintained the same image quality.  
 
 




Partan et al. examined the performance of an LCD display versus a CRT display by comparing a 
set of computed tomography scans of the brain. Observers had to rate the presence or absence of 
brain infarctions and found no statistical difference between the two displays. They concluded 
that LCD monitors are feasible to use in a diagnostic setting without significant detriment to 
diagnostic performance [Partan et al., 2003].  
 
Krupinski et al. evaluated observer performance in radiographic interpretation using an LCD and 
CRT displays. Observers were shown imagers of breasts with either a malignant or benign mass 
which they had to correctly diagnose. They concluded that LCDs are suitable for diagnostic 
viewing of radiographic images and provide an even better viewing medium than CRT 
[Krupinski et al., 2004].  
 
2.1.3 Use of displays in Medicine 
 
Almost every field of medicine uses electronic displays in their day to day workflow. These 
displays are used for a variety of tasks including viewing and analyzing medical images. 
Electronic displays have many characteristic features that should be considered before choosing 
one for a specific clinical use. The first noticeable feature is the size of the display, it should have 
the appropriate resolution to properly display the desired medical image at a given viewing 
distance.  
 
Another important feature is the luminance a display can produce. The maximum luminance of a 
display is determined by the maximum brightness the backlight can produce. The minimum 
luminance is determined by the maximum amount of light the panel can “block”. Over time, the 
amount of light generated by the backlight can decrease which results in gradual dimming of the 
display. The backlight also contributes to the display’s luminance uniformity as it has to provide 
perfectly homogenous light. Spatial noise can also affect the displayed image as it can rise from 




Contrast is one of the important image quality characteristics of electronic displays. It’s defined 
as the difference in luminance that makes a structure or object more detectable or distinguishable 
from its surroundings. The contrast of a medical image as perceived by an observer can vary 
based on the average brightness the observer is exposed to. The human eye has a diminishing 
ability to perceive subtle contrast changes as brightness deviates from the point of adaptation. 
The human visual system’s (HVS) contrast threshold can be described with the help of the 
concept of just noticeable difference (JND). A JND represents a perceivable change in luminance 
(ΔL) for a given luminance level. The measured contrast change (ΔL/L) for a JND varies with 
spatial frequency and with the background luminance that the HVS perceives.     
 
Some other important characteristics are ambient ratio, maximum and minimum luminance and 
total combined maximum and minimum luminance. Ambient ratio is defined as the ambient 
luminance divided by the minimum luminance. The minimum luminance describes the 
luminance output when an image with the minimum pixel value is displayed. The total combined 
minimum luminance of the display (L'min) is defined as the sum of the minimum and ambient 
luminance. The maximum luminance describes the luminance output when an image with the 
maximum pixel value is displayed. The total combined maximum luminance of the display 
(L'max) is defined as the sum of the sum of the maximum and ambient luminance. The luminance 
ratio (LR) is defined as the total combined maximum luminance divided by the total combined 
minimum luminance.  
 
Displays in the clinic are calibrated and routinely measured to maintain their image quality 
characteristics according to the American College of Radiology (ACR) and the American 
Association of Physicists in Medicine (AAPM).  Table 2.1 summarizes the expected range of 
display characteristics for different types of electronic displays using in medicine. 
 
The need for a high-performance display, specifically in the field of diagnostic radiology, gave 
birth to a subset of electronic displays specifically designed for diagnostic use. The diagnostic or 
medical grade display became the standard in diagnostic radiology due to their high resolution, 




Characteristic Diagnostic Display Non-Diagnostic Display 
Qualitative Ambient 
Luminance/Illuminance 
Ambient Ratio ≤ 1/4 Ambient Ratio ≤ 1/4 
Quantitative Min/Max 
Luminance 
250 < LR < 450 250 < LR < 450 
L'min < 1.0 cd/m
2 L'min < 0.8 cd/ m
2 
L'max > 350 cd/ m




Deviation from DICOM GSDF 
< 10% 




∆D65 (u', v') ≤ 0.01 ∆D65 (u', v') ≤ 0.02 
Table 2.1: Characteristic difference between a diagnostic display and a non-diagnostic display [Samei et al., 2005; Bevins et al., 
2019]. 
 
Yamada et al. compared a 3 megapixel (MP, expresses the number of display elements) and a 5-
megapixel medical grade displays with hard copy film. They concluded that the two displays are 
equivalent to hard copy film when used to view a set of mammography radiographs [Yamada et 
al., 2008].  
 
One of the biggest drawbacks of Medical grade displays is their cost. They cost tremendously 
more than a commercial grade display (The medical grade display used in this study has an 
average retail price of $12,000 and the commercial grade display has an average retail price of 
$500). In recent years studies continued to evaluate medical grade displays and compare them 
with a wide variety of commercial grade displays to justify cheaper options. Without 
compromising on diagnostic performance.  
 
Krupinski compared a medical grade display with a commercial “off the shelf” display by having 
observers view a set of chest radiographs and attempt to diagnose pulmonary nodules. She 
concluded that the medical grade display performed better than the commercial grade display. 
She demonstrated that after one year of use the commercial grade display has degraded enough 
to negatively impact diagnostic and visual search performance. She also recommends that if a 
commercial grade display is to be used, it should be calibrated and evaluated on a regular basis 




Liukkonen et al. compared the detection accuracy of subtle chest lesions on a digital chest 
radiograph using a medical grade and commercial grade displays. The study was performed 
under two different ambient room illumination: bright and dim. They concluded that a 
commercial grade display with or without calibration is not suitable for viewing images in bright 
ambient room illumination (sensitivity of 71% vs 57% and accuracy of 75% vs 67%). Bright 
ambient room illumination degrades the quality of the image displayed by lowering its contrast. 
However, in dim room lighting they found no significant different between the two displays 
[Liukkonen et al., 2016].  
 
A similar study by Kallio-Pulkkinen et al. compared the detectability of caries in bitewing 
radiographs using a medical grade and a commercial grade display. They concluded that 
calibrating a commercial grade display improves its detectability particularly in bright ambient 
room illumination [Kallio-Pulkkinen et al., 2016]. Pinto dos Santos et al. made the comparison 
between a calibrated commercial grade and medical grade displays in the detection of subtle 
bone fissures. They found no statistical difference with regards to their diagnostic performance 
[Pinto dos Santos et al., 2017].  
 
 




When the use of digital medical images became popular in the early 1980s the need for an 
imaging standard arose. The ACR and NEMA (The National Electrical Manufacturers 
Association) created several working groups and committees to formulate a standard. In 1993 
they released the Digital Imaging and Communications in Medicine (DICOM) standard. Since 
then, DICOM is the most used format for storing and transmitting medical images. In addition, 
work has been done to create a calibration process for electronic displays such that they can 




The DICOM standard is based on Barten’s assessment of the contrast threshold of the human 
eye. In his experiments, Barten used a square target with modulation of four cycles per degree 
with a fixed background. Observers had to determine if they detect the individual pattern 
elements at a given luminance level. He was able to calculate the average HVS response and 
describe a JND for each background luminance level. He showed the nonlinearity in the HVS as 
the percentage of contrast change required for a JND at low background luminance was higher 
than that for a JND at a higher background luminance as shown in figure 2.3 [Barten, 1999].  
 
 
Figure 2.3: DICOM grayscale standard function shown as luminance versus JND indices. A JND change of 1 will produce a 
relative luminance change equal to the peak to peak contrast threshold.   [NEMA, 2006]. 
 
Medical images are much more complex than the patterns used by Barten.  The observers in his 
experiments adapted to the background luminance level before each trial. This is known as 
variable adaptation. When viewing a medical image an observer will adapt to an average 
background luminance composed of many different luminance values in what is referred to as 
fixed adaptation.  Due to this type of adaptation, observers might not be able to perceive the 
image details that are contained outside the luminance range that their eye has adapted to. In 
order to maximize the perceptibility of the information presented in a medical image, one must 
create perceptual linearity across all grayscale values. This means that the change in pixel values 
throughout a grayscale range appears to have similar contrast. This ensures that information at 
one luminance level is not lost at the expense of visibility at other levels. Perceptual linearity can 
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be achieved by setting display luminance values such that each change in pixel value 
corresponds to the same quantity of JND.  
 
2.2.2 Gray Scale Display Function (GSDF) 
 
As previously stated, DICOM calibration aims to maximize the perceptibility of the medical 
image displayed. This can be achieved by creating perceptual linearity across all grayscale 
values, where any change in image pixel value throughout a grayscale range has a similar 
contrast. In practice the calibration is done by setting the display luminance values such that each 
change in pixel value corresponds to the same quantity of JND. The calibration process was 
published as part of the DICOM grayscale display function (GSDF) part 14 publication [NEMA, 
2006]. The GSDF specifies the precise display luminance that should be produced for a given 
input value. This assures that different displays can be set to have the same grayscale response. 
Figure 2.4 shows the grayscale response of a display before and after DICOM GSDF calibration.   
 
 





One of the limitations of the DICOM GSDF is that while a JND unit is derived using variable 
adaptation, actual medical images are usually viewed under fixed adaptation. Images will only 
have similar appearance when displayed using the same luminance range. As the luminance level 
increases, the detail in the image will depart from the adaptation luminance level.  
 
Bath et al. showed that for a DICOM GSDF calibrated display the perceived contrast increased 
in all parts of the image when the luminance range increased [Bath et al., 2006]. However, if an 
image is displayed on a display with a substantially different luminance range it will be 
perceived as different. Sund et al. evaluated a method of calibrating electronic displays that 
includes the effect of fixed adaptation. By using the DICOM standard test target and the two 
alternative forced choice method, they determined the contrast threshold of each display at a 
given luminance level [Sund et al., 2015].  
 
Another limitation of the DICOM GSDF is the background used for the determination of the 
visual contrast threshold. Barten and others used sinusoidal patterns displayed over a uniform 
background. While a uniform background is needed for experimental work it does not represent 
actual clinical images. Leong et al. examined how a complex background can affect the DICOM 
GSDF calibration and the perceived medical image information. Their study showed there is no 
statistically significant difference in contrast detection between the different background levels 
used in the study. They concluded that the GSDF calibration maintained perceptually 
linearization detection performance across shifts in median background intensity for all displays 
in the study [Leong et al., 2012].    
 
 




Over the past six decades multiple studies have investigated the visual threshold of the human 
eye. One of the most important Human visual thresholds is the contrast threshold. The contrast 
threshold describes the minimum contrast at which an object can be detected. This threshold can 
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vary with spatial frequency and other physical parameters such as luminance level and stimulus 
size. Contrast sensitivity describes the eye’s ability to distinguish low contrast patterns and is 
also as the inverse of contrast threshold. In general, the contrast threshold increases, and the 
contrast sensitivity decreases as the average luminance of an image decreases.  
 
DePalma et al. measured the response of the HVS to sine and square waves spatial distribution 
using the threshold criterion of contrast sensitivity [DePalma et al., 1962]. Results indicated an 
interaction between to basic mechanisms in the visual system characterized as a low-pass filter 
and a high-pass filter. Van Meeteren et al. described the modulation sensitivity functions of the 
human eye, as measured with spatial sine wave patterns. They also discussed the relation of 
signal to noise ratio with respect to luminance and how it can be used to improve resolution and 
contrast sensitivity [Van Meeteren et al., 1972].  
 
2.3.2 Contrast Threshold Across Various Displays 
 
As stated in section 2.2.1, Barten developed a mathematical model representing the contrast 
threshold of the HVS, which the DICOM standard was based upon [Barten, 1999]. With the 
rising popularity of electronic displays, especially in viewing of medical images, studies began to 
evaluate the contrast threshold of observers using electronic display devices as a tool to evaluate 
image quality.  
 
Wang et al. evaluated the contrast detail characteristic of several display devices. First, the 
contrast threshold was obtained when observers viewed test images and recorded the minimum 
contrast level at which objects in the image were detectable. The contrast detail characteristic 
was then obtained by plotting the contrast threshold against the size of the object in each test 
image.  The study compared several different CRT monitors and digital projectors. The contrast 
detail characteristic of these displays was measured under various gamma and display settings. 
The results showed the affect ambient illumination has on the contrast threshold specially with 
the digital projectors. Gamma setting and display brightness also heavily affect the contrast 
threshold [Wang et al., 2000]. Spekowius also examined CRT display systems, and compared 
monochrome displays with color displays. The study used a two-dimensional Fourier analysis of 
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special test images with white noise. The results showed four factors that determine the 
perceived image quality of a monitor: luminance, contrast, resolution and noise [Spekowius, 
1999].  
 
 Samei et al. compared the contrast detail performance of five LCD displays with CRT displays 
in medical applications. The study used images of a contrast detail phantom and was evaluated 
by observers with clinical experience. The results showed no statistical significance between the 
displays although the LCDs had subtle but superior contrast detectability [Samei et al., 2008]. A 
similar study by Geijer et al. compared an LCD monochrome display with a color LCD display 
by looking at the image quality difference between the two. They concluded that the displays had 
very small differences while reading contrast detail images [Geijer et al., 2007].  
 
Dorr et al. evaluated the precision of contrast sensitivity function using a tablet device. The study 
compared two methods for assessment of contrast sensitivity functions. The results showed both 
methods were highly correlated, but the rapid method delivered more precision [Dorr et al., 
2017]. Mulligan tested another method for rapid measurement of contrast sensitivity on mobile 
touch screen devices. The results show agreement with estimates obtained from traditional 
psychophysical methods as well as other rapid estimation techniques [Mulligan, 2016].  
 




The radiation oncology workflow utilizes medical images in almost every step of the treatment 
process. The first phase of the workflow is called the treatment planning phase when the course 
of radiation treatment is planned based on a set of computed tomography (CT) images of the 
patient. The planner (a dosimetrist) will contour (draw) the organs in areas that might receive a 
dose of radiation either directly or indirectly. The healthy tissue will be labeled as organs at risk 
(OAR) while the tumor will be labeled as part of the planning target volume (PTV). The tumor is 
usually contoured by the physician (a radiation oncologist) while the rest of the plan will be 



















Treatment delivery is the next phase in the radiation oncology workflow. Before the treatment 
plan is executed, medical images are used to verify the position of the patient to insure accurate 
treatment of the PTV. A medical professional (a radiation therapist) will acquire a set of images 
daily and compare the position of the patient with the image set used in the planning phase. The 
radiation therapist can then adjust the position of the patient six dimensions (vertical, lateral, 
longitudinal, rotation, pitch, and roll). These correctional shifts will be performed every day 
throughout the course of treatment based on the daily images they acquire. An example of the 
image comparison between the planning and treatment images is seen in figure 2.6. 
 
Figure 2.5: Examples of treatment planning contours. The CT scan of the brain (left) with the eye contour in blue and 




Figure 2.6: An example of a patient positional adjustment based on daily imaging. The daily images of a patient with lung cancer 
is compared with the planning image set prior to treatment. The daily image is represented by the brighter section labeled 
“Daily” while the planning image is labeled “Planning”. 
 
Occasionally, patients with advance disease will require a different method of treatment that is 
commonly referred to as a special procedure. Their treatment will require a large dose of 
radiation to a small area of the body over a short period of time (1 to 5 treatments versus the 
conventional 20 to 45 treatments). Therefore, their treatment planning and delivery requires a 
much higher precision and accuracy than previously stated. In most cases, the treatment plan will 
be calculated using two or more medical imaging modalities that will be fused together for 
optimal disease localization and visualization.  
 
2.4.2 Uncertainties in Medical Images 
 
The goal of every radiation treatment plan is to treat the cancerous area without harming any 
healthy tissue. The Quality of a treatment plan depends on the accuracy, precision and 
consistency of the person who plans it. The outcome of the plan often relies on accurate organ 
identification and proper contouring of the OARs and the PTV. This can introduce several 
uncertainties that are associated with contouring the PTV and the OARs as they depend on the 






Several studies have examined the variations in contouring within a group of dosimetrists and the 
consistency of each dosimetrist when contouring OARs, and the resulting clinical implications. 
Collier et al. assessed the consistency of contouring normal anatomical structures. They asked 
six observers to contour normal OARs (the heart, esophagus and spinal cord). The study 
concluded that contouring anatomical structures can vary drastically between dosimetrists and 
the discrepancies could be substantial. In addition, the study mentioned the resulting 
discrepancies do not seem to correlate with the experience of the dosimetrist [Collier et al., 
2002].  
 
Nelm et al. examined the variations in contouring OARs in a patient with oropharyngeal cancer. 
Their dataset was compiled from 32 different contours of the same patient from different clinics 
and institutions. They found substantial dose difference resulting strictly from contouring 
variations [Nelm et al., 2012].  
 
Lorenzen et al. examined the variation in contouring the heart and left anterior descending 
coronary artery in breast cancer patients. Nine observers were tasked with contouring the OARs 
twice. Their results show very little inter-observer variation, but substantial intra-observer 
variation was observed especially when the left anterior descending coronary artery was 
contoured [Lorenzen et al., 2013].   
 
Genovesi et al. examined the inter-observer variability in contouring treatment volumes in soft 
tissue sarcomas. Seventeen observers were used in this study and were instructed to contour the 
image dataset of two patients. Results showed several variations that affected the volume of the 









3 Visual Contrast Sensitivity of Human Observers 
 
In this chapter an experiment measuring the contrast sensitivity of the HVS is discussed. The 
experiment was designed to measure the contrast sensitivity to changes in background 
luminance, ambient room luminance and electronic display calibration. In addition, each 
electronic display was characterized by measuring their luminance response. The results would 
be compared between the two electronic displays for their similarities and differences.    
 




The contrast sensitivity of the HVS has been long measured and documented. The ability to 
notice and distinguish small differences in luminance levels is crucial, especially when analyzing 
medical images. Before the image quality performance of two different displays can be 
compared, first they need to be characterized. In this section, the luminance response of two 
electronic displays was measured and compared to the DICOM GSDF standard.  
 
3.1.2 Experimental Setup 
 
Two electronic displays were used in this experiment: a high-performance LCD color display 
and a conventional LCD color display. The high-performance display (MGD) was a Barco 
Coronis Fusion and the conventional display (COTS display) was a NEC Multisync. A summary 










 Barco Coronis Fusion 
4MP 
NEC Multisync ea234wmi 
Screen technology IPS-TFT color LCD IPS color LCD 
Active screen size (H x V) 655 x 410 mm 476.1 x 267.8 mm 
Aspect ratio (H:V) 16:10 16:09 
Resolution 2560 x 1600 1920x1080 
Pixel pitch 0.256 mm 0.27 mm 
Color/Gray imaging Yes/Yes Yes/Yes 
Bit depth 10 bit 8 bit 
Ambient Light Compensation (ALC) 
Yes, reading room 
selection 
No 
Ambient light sensor Yes No 
Maximum luminance (panel typical) 1050 cd/m² 250 cd/m² 
DICOM calibrated luminance 600 cd/m² N/A 
Contrast Ratio 1500:1 1000:1 
Pixels Per Inch 99 96 
Table 3.1: The specification of each display used in this experiment. 
 
Each display was connected to the same workstation using the same graphics card (AMD 
FIREPRO MXRT-5600 by Barco), and used with their default setup and calibration. The 
luminance response of each display was measured with a Raysafe X2 light sensor. The 
measurements were taken in a dark room with ambient luminance of 0.25 cd/m2.  
 
 
3.1.3 Targets  
 
Eighteen targets were created for the luminance response measurement as shown in figure 3.1. 
The targets were generated based on the recommendations of AAPM TG270 for luminance 
response measurements [Bevins et al., 2019]. The targets are designed to be uniform in color and 
cover the 8-bit grayscale range (0 to 255) in steps of 15. Each target was measured by placing the 








3.1.4 Results and Discussion 
 
As previously described, the luminance response of each display was measured at eighteen 
different grayscale levels. The results are plotted for each display are shown in figure 3.2. The 
luminance response of each display was compared with the response of the theoretical DICOM 
GSDF curve with upper and lower bounds of 15% as recommended by AAPM TG270 [Bevins et 
al., 2019]. A luminance response within the bounds of the GSDF is an indication of a correctly 
DICOME GSDF calibrated display. 
 
The results for the measurements show that the high-performance display is properly calibrated 
and follows the GSDF curve. The response of the conventional display, on the other hand, 
drastically varied from the DICOM GSDF curve and appears to be improperly calibrated or not 
calibrated at all. Interestingly, two identical conventional displays were measures and even 
among themselves showed some variance in the luminance response when compared with each 
other.  
 
Figure 3.1: 18 targets used in the experiment. Each target was measured individually on each display. 
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The luminance response of an electronic display is one of its defining characteristics. The 
luminance performance at every grayscale level has a large impact on the perceived medical 
image. Therefore, the ACR and AAPM require electronic displays that are used in the primary 
interpretation of medical images to be DICOM GSDF calibrated. The calibration linearizes the 
perceived luminance of a display without changing its luminance dynamic range. A consistent 
luminance response between different displays will insure similar image presentation to 
observers.  
 
Figure 3.2: The luminance response of the medical grade display (top) and the consumer grade display (bottom) as compared 





The luminance response of an electronic display is one of the most important features that can 
have an influence on how a medical image is interpreted. The luminance response is also an 
indication whether a display was calibrated to DICOM GSDF correctly. For this purpose, the 
luminance response of each display used in this study was measured and compared with the 
DICOM GSDF. A calibrated display allows for consistent image appearance as the DICOM 
GSDF is a good predictor for the contrast response of the human visual system.   
 
The results show that, the high-performance display was DICOM GSDF calibrated “out of the 
box” while the conventional display varied significantly from the DICOM GSDF curve.  
 




As mentioned in the previous section, image contrast is an important image quality characteristic 
that allows for the detection of subtle luminance difference in a medical image. The threshold 
between the perceived and overlooked is based on the contrast sensitivity of the human eye. 
Since most clinical departments now depend on electronic displays to view and analyze medical 
images, the visibility and detectability performance of a display is a critical component in the 
patient care workflow. As described in chapter 2, the contrast threshold can vary with spatial 
frequency, luminance level or stimulus size.  
 
Medical images are viewed and analyzed using electronic displays under various conditions. In 
section 3.1 the importance of DICOM GSDF calibration was measured and discussed. However, 
these measurements did not involve human observers as the luminance response of the electronic 
displays was measured using a photometer. In this section an experiment was designed to 






3.2.2 Experimental Setup 
 
Two electronic displays were used in this experiment: a high-performance and a conventional 
display. The specifications of each display are summarized in table 3.1. Each display was 
connected to the same workstation using the same graphics card and used in their default setting. 
The displays were viewed at a viewing distance of 1 meter by each observer. The experiment 




Fifteen observers participated in the experiment with an age range of 30 to 45 years old. Of the 
fifteen observers, seven were males and eight were females. Each observer was tasked with 
detecting a bar pattern on patches with different grayscale levels at different luminance 
backgrounds. Observers were asked to look at each grayscale patch and state whether they detect 
a pattern. Before each trail the observers were given ten minutes to adapt to any changes in 
ambient room illumination.  
 
3.2.4 Test Images 
 
The test images used in this experiment are a modified version of the AAPM TG270 sQC target 
as seen in figure 3.3 [Bevins et al., 2019]. This specific test image was chosen as it is currently 
the recommended target for visual evaluation of display performance in diagnostic radiology. 
The target is designed with 18 gray level patches that cover the 8-bit grayscale range from 0 to 
255 in 15 gray level increments. Each patch has a modulating bar pattern in the upper left and 
lower right corner. The modulating bar pattens will vary from the background of each patch by 
+/- 1 gray level. Test images were created with four different modulating bar patterns (2, 4, 6, 8 
pixels per line pair or 17, 8.4, 5.6, 4.2 cycles per degree) and three different luminance 











































3.2.5 Results and Discussion 
 
The contrast sensitivity of human observers using the three different luminance backgrounds, 
three different ambient room illumination and modulating bar pattern are presented in figures 3.4 
to 3.6.  
 
 
Figure 3.3: The test image used in the experiment. Fifteen gray level patches of 8-bit levels from 0 to 255 with 
modulating bar patterns in the upper left and lower right corners. On the right on the test image and example is 



























Figure 3.4: Contrast sensitivity results from the consumer grade display (top) and the medical grade display (bottom). The test patterns 































Figure 3.5: Contrast sensitivity results from the consumer grade display (top) and the medical grade display (bottom). The test patterns 
































Figure 3.5: Contrast sensitivity results from a consumer grade display (left) and a medical grade display (right). The test patterns were 
displays over a white [255,255,255] background, and utilized 3 different room illuminations (Dark, Dim, and Bright). 
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The results were averaged for all observers and converted to a probability function that was  
plotted against the grayscale level of all test patterns. Each plot was fitted with a gaussian fit and 
the full width at half maximum (FWHM) was calculated. The shape of the curve, mainly the 
width of the FWHM, can shed some light on the range of detectability between the two displays 
used in this study. The FWHM of each display can be seen in tables 3.2 to 3.4. 
 
Illumination Background Line Pair FWHM MGD FWHM COTS 
Dark 0 2 75.2 28.8 
Dark 0 4 94.9 60.9 
Dark 0 6 161.2 107.1 
Dark 0 8 221.3 153.8 
Dim 0 2 74.2 32.1 
Dim 0 4 94.1 51.8 
Dim 0 6 163.7 118.1 
Dim 0 8 220.6 134.9 
Bright 0 2 72.4 34.9 
Bright 0 4 93.8 48.5 
Bright 0 6 158.6 64.3 
Bright 0 8 219.6 95.1 
Table 3.2: The full width at half maximum (FWHM) of both displays taken from the plots in figure 10. 
 
 
Illumination Background Line Pair FWHM MGD FWHM COTS 
Dark 128 2 77.8 38.0 
Dark 128 4 93.3 63.5 
Dark 128 6 161.2 94.4 
Dark 128 8 216.2 151.7 
Dim 128 2 75.7 38.0 
Dim 128 4 93.6 59.7 
Dim 128 6 161.9 88.2 
Dim 128 8 221.9 115.8 
Bright 128 2 70.3 34.9 
Bright 128 4 94.6 46.4 
Bright 128 6 154.0 58.7 
Bright 128 8 211.4 81.1 





Illumination Background Line Pair FWHM MGD FWHM COTS 
Dark 255 2 72.9 32.4 
Dark 255 4 93.8 53.6 
Dark 255 6 152.0 82.4 
Dark 255 8 197.1 137.4 
Dim 255 2 70.9 25.0 
Dim 255 4 93.0 55.8 
Dim 255 6 157.0 89.8 
Dim 255 8 208.1 119.6 
Bright 255 2 63.5 37.0 
Bright 255 4 90.8 46.9 
Bright 255 6 150.0 69.6 
Bright 255 8 200.2 91.5 
Table 3.4: The full width at half maximum (FWHM) of both displays taken from the plots in figure 12. 
 
A gaussian fit is a non-linear model which will require a non-linear regression analysis and 
goodness of fit. The sum of squares due to error (SSE) was used to measure how close the data is 
to the fitted regression curve. The SSE measures the total deviation of the fit values from the 
measured values as seen in equation 3.1. Alternatively, it can also be an indication of the 
goodness of fit model. A small SSE value will indicate a better fit as it shows that the 
observations are closer to the fitted regression curve. In this experiment the maximum SSE value 
for the medical grade display curve fit model was 0.167, while the maximum value for the 
consumer grade display curve fit model was 0.143.   
 
𝑆𝑆𝐸 =  ∑ 𝑤𝑖(𝑦𝑖 − ?̂?𝑖 )
2𝑛
𝑖=1                                                   (3.1) 
 
The results of the experiment can be divided into three main groups:   
• Contrast sensitivity with variable ambient room illumination.  
• Contrast sensitivity with variable background luminance.  
• Contrast sensitivity with variable bar pattern modulation.  
 
Within the first group, the high-performance display showed a wider detectability range than the 
conventional display at every background luminance and bar pattern modulation level.  In most 
cases, both displays performed the best while in the dark ambient room illumination and worst 
when in the bright ambient room illumination. The conventional display was more affected by 
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ambient room illumination than the high-performance display. This is indicative to how medical 
images are viewed, as most diagnostic images are viewed in a dark ambient room illumination, 
and most medical images in radiation oncology are viewed in a dim ambient room illumination.  
 
Within the second group, the high-performance display also had a wider range of detectability at 
different background luminance. Furthermore, the contrast sensitivity seems to be almost 
independent of background luminance. This is a result of the DICOM GSDF calibration of the 
display, as the contrast sensitivity is linearized over its entire luminance range. The conventional 
display on the other hand, showed variance in its detectability over different background 
illumination that were not consistent with any pattern. Again, this is an example of how the lack 
of display calibration can affect the visualization and detectability of medical images.  
 
Within the third group, the range of detectability increased as the bar pattern modulation 
increased as expected. The high-performance display has shown a wider range of detectability in 




The results of this experiment showed that a high-performance display has a wider range of 
detectability when compared with a conventional display. One of the contributing factors to the 
detectability and contrast sensitivity difference is DICOM GSDF calibration and perceptual 
linearization of the contrast sensitivity function across at all luminance levels following the 
DICOM GSDF part 14 [NEMA, 2006].  
 
A DICOM GSDF calibrated display will exhibit relatively constant detectability range across 
different backgrounds, ambient room illumination and bar pattern modulation, while a non-








4 Clinical image comparison 
 
In this chapter a comparison of the perceived image quality between two different electronic 
displays is discussed. Several experiments were designed to evaluate and compare a high-
performance and a conventional display within a clinical radiation oncology workflow. 
Observers were tasked with rating the image quality using each display while performing 
different phases of the radiation oncology workflow.  
 
The results of each experiment will be evaluated and compared between the displays for their 
similarities or dissimilarities.  Section 4.1 discusses the treatment planning phase of the 
workflow; section 4.2 discusses the treatment delivery phase of the workflow and section 4.3 
discusses the special procedures phase of the workflow.  
 




The accuracy and precision of a radiation treatment plan hinges on the perceived image quality 
of the medical images that are used to create it. Medical images often contain small and subtle 
features that could be critical for successful treatment. Electronic displays can affect how an 
observer perceives these features and thus influences the overall quality of the treatment plan.   
 
 In this section, an experiment was created to compared observers’ image quality preferences 
between two displays, high-performance and conventional displays.  
 
4.1.2 Experimental Setup 
 
Two different electronic displays were used in the experiment: a high-performance LCD color 
display and a conventional LCD color display. The high-performance display (MGD) was 
chosen to be a Barco Coronis Fusion and the conventional display (COTS display) was chosen to 
be a NEC Multisync. The characteristics of each display is summarized in table 3.1. 
 
Forty CT image sets of various areas of patients’ bodies were used in this experiment. The scans 
were acquired using a 64 slice Siemens SOMATOM Confidence RT CT scanner. Each scan 
33 
 
belongs to a patient that is currently under or recently completed their treatment. The number of 
CT scans per treatment site is summarized in table 4.1. 
 











Table 4.1: The number of CT scans per treatment site 
 
The displays were connected to the same workstation using an AMD FIREPRO MXRT-5600 
graphics card. Each display was used in its default setup and calibration. The medical images 
were displayed using the Varian Eclipse treatment planning software. The viewing room was 
illuminated with a mixture of natural and artificial lighting and was kept at a constant level 
between trials as possible. The displays were places side by side and viewed at a constant 




Five certified dosimetrists participated in the experiment, each with at least five years of clinical 
experience. The group consisted of three females and two males, with ages ranging from 28 to 55 
years old. In addition, two certified radiation oncologists participated in the experiment, each 
with at least four years of post-certification clinical experience. The group consisted of one 
female and one male, with ages ranging from 35 to 45 years old. All of the observers reported to 
having normal or corrected vision. 
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4.1.4 Experimental Procedure 
 
In each trial observers viewed a medial image on both displays simultaneously and were tasked 
with comparing and rating the image in three categories: contrast, sharpness and resolution. Each 
category was defined to the observers as follows: 
a) Contrast, the difference in luminance or color that makes a structure or object more 
detectable or distinguishable from its surroundings. 
b) Sharpness, the crisp non-graduate boundary between two colors or shades of gray. Blur 
will cause that boundary to degrade and lose sharpness. 
c) Resolution, the ability to differentiate between two objects. If an image has low resolution 
it will be difficult to distinguish two objects that are close together. 
 
The rating scale used in this experiment is similar to a 5-point Likert scale [Likert, 1932] and each 
observer chose between the following categories:  
• Display A (MSG) much better than Display B (COTS). 
• Display A slightly better than Display B.  
• Equal performance. 
• Display B slightly better than Display A. 
• Display B much better than Display B.  
 
The rating scale results were analyzed using the visual grading characteristics (VGC) analysis 
[Bath and Mansson, 2007].  VGC analysis characterizes observers’ opinions about a modality or 
criteria. The first step in the analysis is to create a frequency table that summarizes the results for 
each display. Next, the VGC curve data points are calculated as the cumulative frequency of each 
image quality category. Similar to a receiver operating characteristics (ROC) curve, the origin of 
a VGC curve is at “0” and the last point is the sum of all decisions and is therefore equal to “1”.  
 
MATLAB was used to record the rating scale and calculate the VGC data points as well as plot 
each curve. An area under the curve (AUC) was calculated for each plot, it represents the difference 
in image quality between the two displays.  
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Standard statistical tests were used for calculating confidence intervals and p-values from the 
obtained values of the AUC and its standard deviation. A p-value of <5% was considered as the 
significance threshold in this experiment. 
 
4.1.5 Results and Discussion 
 
The image quality data was analyzed using the VGC analysis method as previously described 
[Bath and Mansson, 2007]. The VGC data points were then plotted resulting in a VGC curve. 
From the plot, a VGC AUC was calculated for each image quality category. The VGC curves 
and AUCs for the dosimetry group are shown in figures 4.1 to 4.3 and for the physician group in 
figures 4.4 to 4.6.    
 
 
Figure 4.1: Visual grading characteristics curve of the contrast image quality comparison between the high-performance and 





Figure 4.2 Visual grading characteristics curve of the resolution image quality comparison between the high-performance and 
conventional displays for the dosimetry group. Display A was the MGD and Display B was the COTS display. 
 
Figure 4.3: Visual grading characteristics curve of the sharpness image quality comparison between the high-performance and 




Figure 4.4: Visual grading characteristics curve of the contrast image quality comparison between the high-performance and 
conventional displays for the physician group. Display A was the MGD and Display B was the COTS display. 
 
Figure 4.5: Visual grading characteristics curve of the resolution image quality comparison between the high-performance and 




Figure 4.6: Visual grading characteristics curve of the sharpness image quality comparison between the high-performance and 
conventional displays for the physician group. Display A was the MGD and Display B was the COTS display. 
 
The results of this experiment show that both observer groups chose Display “A” (MGD) as the 
display that provided better image quality in all three categories when used to create a treatment 
plan. In addition, observers indicated that the MGD helped visualize organs at risk and the tumor 
volume better than the COTS display.  
 
Within the dosimetry group, the VGC AUC for the contrast category was 0.929 with a standard 
deviation of 0.0133. The 95% confidence intervals for the AUC (0.896, 0.950) did not cover the 
0.5 equal performance line which indicates that the MGD had better perceptual contrast than the 
COTS display. Similarly, the VGC AUC for the sharpness category was 0.904 with a standard 
deviation of 0.0151 and 95% confidence intervals of (0.873, 0.935) and the VGC AUC of the 
resolution category was 0.915 with a standard deviation of 0.0151 and 95% confidence intervals 
of (0.886, 0.944). Again, in both cases the AUC did not cover the 0.5 equal performance line 




Within the physician group, the VGA AUC for the contrast category was 0.899 with a standard 
deviation of 0.0246 and 95% confidence intervals of (0.850, 0.948). Similarly, the VGC AUC for 
the sharpness category was 0.907 with a standard deviation of 0.0234 and 95% confidence 
intervals of (0.860, 0.954) and the VGC AUC of the resolution category was 0.887 with a 
standard deviation of 0.0263 and 95% confidence intervals of (0.821, 0.933). As stated before, in 
all three cases the 95% confidence intervals did not cover the 0.5 equal performance line which 
indicates that the MGD performed better than the COTS display in all three categories.  
 
One of the major differences between the two displays is that the MGD is designed to have high 
luminance, high contrast ratio, and high resolution such that it could be used in interpretation of 
medical images in diagnostic radiology. Another key difference between the two displays is 
DICOM GSDF calibration. On the other hand, the cost of a COTS display is significantly lower 
than that of an MGD, yet it is important to consider the long-term performance. It has been 
shown that commercial grade displays degrade rapidly over time and tend to be unstable without 
proper monitoring and calibration [Krupinski, 2009].  
 
4.1.6 Summary  
 
An image quality comparison experiment using two types of displays was designed and 
constructed to examine observer perceptual preference when used to view medical images to 
create a radiation oncology treatment plan.  
 
Seven observer results were analyzed for their perceptual image quality preference in three 















As stated in section 4.1, the radiation oncology workflow relays heavily on medical images. 
Creating and calculating an accurate treatment plan is only half of the workflow, as the plan also 
needs to be correctly delivered to each patient. The positioning of the patient prior to treatment is 
verified using daily acquired medical images. These images are compared with the treatment 
planning images using an electronic display. Similar to the treatment planning phase, the 
electronic display can influence how the observer perceives these images and thus can influences 
the overall accuracy of the treatment delivery.   
 
 In this section, an experiment was created to compare observers’ image quality preferences 
between two displays, high-performance and conventional displays. In addition, the experiment 
also compared the time it took to analyze and fuse the planning and delivery image sets, and the 
magnitude of the patient’s positional correction.  
 
4.2.2 Experimental Setup 
 
Similar to the experiment described in section 4.1, the same high-performance LCD color 
display and conventional LCD color display were used in this experiment. The characteristics of 
each display is summarized in table 3.1. 
 
Forty sets images of various areas of patients’ bodies were used in this experiment. The treatment 
planning scans were acquired using a 64 slice Siemens SOMATOM Confidence RT CT scanner. 
The treatment position verification scans were acquired using the treatment machine’s onboard 
cone-beam computed tomography (CBCT) imager (Varian OBI Truebeam 2.7). The treatment 
position verification images were acquired daily while the treatment planning images remained 
the same at each trial. The images were viewed, fused and analyzed using the 4DITC image 














Table 4.2: The number of CT scans per treatment site 
 
Both displays were connected to the same workstation using an AMD FIREPRO MXRT-5600 
graphics card. Each display was used in their default setup and calibration. The viewing room 
was illuminated with dimmed artificial lighting and was kept at a constant level between trials as 





Six certified radiation therapists participated in the experiment, each with at least five years of 
clinical radiation therapy experience. The group consisted of five females and one male, with 
ages ranging from 30 to 47 years old. All of the observers reported to having normal or corrected 
vision. 
 
4.2.4 Experimental Procedure 
 
Similar to the experiment in section 4.1, the observers (the radiation therapists) were tasked with 
comparing the perceptual image quality while viewing both sets of medical images using both 
displays.  The observers were asked to use the same rating scale and image quality categories as 




Each Observer was also tasked with performing patient positioning verification. After each 
patient was placed on the treatment table, a CBCT image set was acquired. This image set would 
then be manually fused with the planning CT scan image set and a positional correction was 
calculated in three dimensions (vertical, lateral, longitudinal). The time it took each observer to 
analyze the images, fuse them and perform the positional correction was measured as well as the 
magnitude of the correction itself. 
 
The rating scale results were analyzed using the VGC analysis method as described in section 4.1. 
MATLAB was used to record the rating scale and calculate the VGC data points as well as plot 
each curve and calculate an AUC. Standard statistical tests were used for calculating confidence 
intervals and p-values from the obtained values of the AUC and its standard deviation. A p-value 
of <5% was considered as the significance threshold in this experiment. 
 
4.2.5 Results and Discussion 
 
The results were analyzed using the VGC analysis method as described in section 4.1. The VGC 









Figure 4.7: Visual grading characteristics curve of the contrast image quality comparison between the high-performance and 
conventional displays. Display A was the MGD and Display B was the COTS display. 
 
Figure 4.8: Visual grading characteristics curve of the resolution image quality comparison between the high-performance and 




Figure 4.9: Visual grading characteristics curve of the resolution image quality comparison between the high-performance and 
conventional displays. Display A was the MGD and Display B was the COTS display. 
 
The results of the experiment demonstrate a clear preference for Display “A” (the MGD) over 
Display “B” (the COTS display) in all three image quality categories when used to analyze 
treatment delivery and planning medical images.  
 
When tasked with comparing the contrast between the two displays the VGC AUC was 0.721 
with a standard deviation of 0.024. The 95% confidence intervals for the AUC (0.67, 0.76) did 
not cover the 0.5 equal performance line which indicates a statistically significant preference for 
the MGD. Similarly, the VGC AUC for the sharpness category was 0.614 with a standard 
deviation of 0.271 and 95% confidence intervals of (0.56, 0.64) and the VGC AUC of the 
resolution category was 0.597 with a standard deviation of 0.027 and 95% confidence intervals 
of (0.54, 0.64). Again, in both cases the AUC did not cover the 0.5 equal performance line and 




In addition to comparing the perceptual image quality between the two displays, image analysis 
and fusion time and the magnitude of the patient’s positional correction were also collected. The 
fusion time was defined as the time it took the therapists to visually fuse the treatment image to 
the planning image, while the patient’s positional correction was defined as difference between 
the initial patient position to the final position in three dimensions (vertical, longitudinal, and 
lateral).  
 
When the MGD was used, it took the therapists an average of 54.79 seconds to perform image 
fusion between the planning CT and positional verification CBCT scans (standard deviation of 
18.11 seconds). on the other hand, it took an average of 69.68 seconds (standard deviation of 
23.45 seconds) to do the same fusion using the COTS display.  
 
An Analysis of variance (ANOVA) was performed on these results to examine if they are 
significantly different. Table 4.3 shows the results of the analysis. These results have statistically 
significant difference (P = 0.0089) and indicate the therapists took longer to visually analyze and 
fuse the images while using the COTS display.  Figure 4.10 shows the box plots comparison of 
the time it took the therapists to analyze and fuse the CT and CBCT images using both displays. 
The top and bottom edges of the blue box show the 75th and 25th percentile of the data. The red 
line inside each box shows the median while the black outer line shows the range between the 
minimum and maximum points.  
 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F (p) 
Time 3325 1 3324.99 7.32 0.0089 
Error 26343.5 58 454.2   
Total 29668.5 59    




Figure 4.10: Box plot comparison of the time it took to analyze and fuse CT and CBCT scans using the MGD (1) and COTS display 
(2). 
 
Another ANOVA analysis was performed on the positional shifts results to examine if they are 
significantly different. The mean shifts in the vertical, longitudinal and lateral directions with 
their standard deviations are shown in table 4.4 and the results of the ANOVA analysis are 
shown in tables 4.5 to 4.7. It is notable that the P value for each directional shift did not reach 
statistical significance. Figures 4.11 to 4.13 show the box plots for the vertical, longitudinal and 
lateral positional shifts while using the two displays. The top and bottom edges of the blue box 
show the 75th and 25th percentile of the data. The red line inside each box shows the median 
while the black outer line shows the range between the minimum and maximum points. The data 







 MGD COTS 
Direction Mean (cm) Standard Deviation (cm) Mean (cm) Standard Deviation (cm) 
Vertical 0.228 0.181 0.259 0.166 
Longitudinal 0.324 0.283 0.356 0.210 
Lateral 0.323 0.257 0.387 0.214 
Table 4.4: The magnitude of the positional correction of the three degrees of motion after image fusion for both displays. 
 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F (p) 
Vertical shift 0.0097 1 0.0097 0.3066 0.583 
Error 1.2061 38 0.0317   
Total 1.2159 39    
Table 4.5: Analysis of Variance (ANOVA) table for the vertical positional shift between the two displays. 
 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F (p) 
Longitudinal shift 0.01038 1 0.01038 0.16 0.6926 
Error 2.48568 38 0.06541   
Total 2.49606 39    




Source Sum Sq. d.f. Mean Sq. F Prob>F (p) 
Lateral shift 0.03406 1 0.03406 0.74 0.3935 
Error 1.7379 38 0.04573   
Total 1.77196 39    




































Figure 4.11: Box plot comparison of the vertical positional shifts when using the MGD (1) and the COTS 
display (2). 
Figure 4.12: Box plot comparison of the longitudinal positional shifts when using the MGD (1) and the 




















As seen in figures 4.7 to 4.9, observers showed preference for the MGD over the COTS display. 
The results also demonstrated that the MGD provided better perceptual image quality when used 
to perform IGRT image analysis before each treatment. The results also demonstrate that the 
MGD helped visualize medical images better than the COTS display.  More specifically, the 
results show better image quality perception by the observers which is critical when analyzing 
daily image prior to treatment. The advantage of the MGD is that it can provide high luminance, 
which makes the entire grayscale range of a medical image more visible. The MGD is also 
DICOM calibrated which distributes the total contrast of the display equally across the grayscale 
range of the display. 
 
In addition, the results also indicate that the therapists took longer to analyze and fuse the two 
image sets when the COTS display was used, yet the magnitude of the positional shift did not reach 
statistically significant difference between the displays. This may suggest that fusion efficiency is 
better with the MGD. Having the ability to perform quicker image analysis and fusion without 
Figure 4.13: Box plot comparison of the lateral positional shifts when using the MGD (1) and the COTS display (2). 
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compromising on accurate positioning can improve the efficiency of treatment delivery. Longer 
fusion times can introduce significant treatment errors as the patient can become restless or move 




An image quality comparison experiment was design to examine the perceived image quality 
difference between two types of displays. Patient verification image sets as part of the treatment 
delivery phase of the radiation oncology workflow were used in this experiment. Six observer 
results were analyzed for their perceptual image quality preference in three categories. In 
addition, the image analysis and fusion time was collected, and the magnitude of the positional 
correction was recorded.  
 
Results have shown observer preference for the high-performance display in all three categories. 
In addition, Observers took less time to analyze and perform image fusion on the MGD yet there 
was no difference in the magnitude of the positional correction between the two displays.  
 
 





The previous sections of this chapter described experiments investigating the perceptual image 
quality using electronic displays within the radiation oncology workflow. Two phases of the 
workflow covered in section 4.1 (treatment planning) and 4.2 (treatment delivery). Withing the 
treatment planning phase there is a subset of treatment plans that are known as special 
procedures. These plans often require much higher radiation dose than the average treatment plan 
and require multiple sets of different medical images.  
 
These types of plans also deliver a much higher radiation dose than the average treatment plan 
over a shorter period of time, which requires an even higher accuracy and precision. Electronic 
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displays also play a critical role as they are used to view and analyze medical images from 
additional imaging modalities such as magnetic resonance imaging (MRI).  
 
Similar to section 4.1, an experiment was created to compare observers’ image quality 
preferences between two displays, a high-performance and a conventional display.  
 
4.3.2 Experimental Setup 
 
Similar to the experiment described in section 4.1, the same high-performance LCD color 
display and conventional LCD color display were used in this experiment. The characteristics of 
each display is summarized in table 3.1. 
 
Fifteen CT image sets of the brain, abdomen and lungs were used in this experiment. The CT 
images were acquired using a 64 slice Siemens SOMATOM Confidence RT CT scanner. The 
MRI scans were acquired using a 3T siemens MAGNETOM MRI scanner. Each CT image set 
belonged to a different patient that is currently under treatment or recently completed their 
treatment. The number of CT scans per treatment site are summarized in table 4.8. 
 






Table 4.8: The number of CT scans per treatment site 
 
Both displays were connected to the same workstation using an AMD FIREPRO MXRT-5600 
graphics card. Each display was set and used in its default setup and calibration. The viewing 
room was illuminated with a mixture of artificial and natural lighting and was kept at a constant 
level between trials as possible. The displays were places side by side and viewed at a constant 
distance (50cm) by each observer. The images were viewed, fused and analyzed using the Varian 






Five certified dosimetrists participated in the experiment, each with at least five years of clinical 
experience. The group consisted of four females and one male, with ages ranging from 32 to 55 
years old. In addition, two certified radiation oncologists participated in the experiment, each 
with at least four years of post-certification clinical experience. The group consisted of one 
female and one male, with ages ranging from 35 to 45 years old. All the observers reported to 
having normal or corrected vision. 
 
4.3.4 Experimental Procedure 
 
Similar to the experiment described in section 4.1.4, observers were tasked with comparing 
medical images and rating them in three image quality categories: contrast, sharpness and 
resolution. In each trial, observers viewed a set of CT and MRI images on both displays 
simultaneously. The results of the experiment were analyzed using VGC analysis as explained in 
section 4.1.  
MATLAB was used to record the rating scale and calculate the VGC data points as well as plot 
the curves and calculate the AUC for each plot. Standard statistical tests were used for calculating 
confidence intervals and p-values from the obtained values of the AUC and its standard deviation. 
A p-value of <5% was considered as the significance threshold in this experiment. 
 
4.3.5 Results and Discussion 
 
The resulting data was analyzed using the VGC analysis method as described in section 4.1. The 
VGC curves and AUCs are shown in figures 4.12 to 4.14 for the dosimetry group and figures 





Figure 4.14 Visual grading characteristics curve of the contrast image quality comparison between the high-performance and 







Figure 4.15: Visual grading characteristics curve of the resolution image quality comparison between the high-performance and 
conventional displays for the dosimetry group. Display A was the MGD and Display B was the COTS display. 
 
Figure 4.16: Visual grading characteristics curve of the sharpness image quality comparison between the high-performance and 




Figure 4.17: Visual grading characteristics curve of the contrast image quality comparison between the high-performance and 
conventional displays for the physician group. Display A was the MGD and Display B was the COTS display. 
 
Figure 4.18: Visual grading characteristics curve of the resolution image quality comparison between the high-performance and 




Figure 4.19: Visual grading characteristics curve of the sharpness image quality comparison between the high-performance and 
conventional displays for the physician group. Display A was the MGD and Display B was the COTS display. 
 
Each observer used both displays to contour the OARs and the tumor volume using MRI and CT 
image sets. The results of this experiment indicate that both observer groups chose display “A” 
(MGD) as the display that provided better image quality in all three categories when used to 
create a treatment plan for a special procedure.  
 
Within the dosimetry group, the VGC AUC for the contrast category was 0.713 with a standard 
deviation of 0.0430. The 95% confidence intervals for the AUC (0.630, 0.796) did not cover the 
0.5 equal performance line which indicates that the MGD had better contrast than the COTS 
display. Similarly, the VGC AUC for the sharpness category was 0.705 with a standard deviation 
of 0.0432 and 95% confidence intervals of (0.622, 0.788) and the VGC AUC for the resolution 
category was 0.761 with a standard deviation of 0.0395 and 95% confidence intervals of (0.684, 
0.838). Again, in both cases the AUC did not cover the 0.5 equal performance line which 




Within the physician group, the VGA AUC for the contrast category was 0.773 with a standard 
deviation of 0.0616 and 95% confidence intervals of (0.653, 0.893). Similarly, the VGC AUC for 
the sharpness category was 0.795 with a standard deviation of 0.0586 and 95% confidence 
intervals of (0.682, 0.908) and the VGC AUC of the resolution category was 0.750 with a 
standard deviation of 0.0641 and 95% confidence intervals of (0.625, 0.875). As stated before, 
the 95% confidence intervals did not cover the 0.5 equal performance line which indicates that 
the MGD performed better than the COTS display in all three categories.  
 
Having an electronic display with high luminance and high contrast ratio allows the observer to 
detect small or subtle features in a medical image that could be very important. In addition, the 
display should be optimized to view medical images from different imaging modalities. Precise 
and accurate image fusion between different imaging modalities depends on proper visualization 
of both sets of images to correctly align them in all three dimensions.  
 
Both observer groups stated that the MDG provided them with better visualization of soft tissue 
when CT images were fused with MRI images. They also stated that image artifacts (for 





A perceptual image quality comparison experiment using two types of displays was designed and 
constructed to examine observer preference when used to create a special procedure treatment 
plan. Seven observer results were analyzed for their perceptual image quality preference in three 
categories.  
 
Results showed observer preference for the high-performance display in all three categories.  
Observers indicated that better visualization of critical organs and tumor tissue helped create a 







With the advancement of computer technology in the late 20th century, the use of medical images 
expanded drastically. Today, numerous diseases and illnesses are diagnosed and treated using a 
variety of medical imaging modalities. Most often, medical images require an electronic display 
to view and analyze the image. Except for diagnostic purposes, no other clinical department has 
established a criteria or standard for the use of displays with their departmental workflow. When 
a medical image is transferred from diagnostic radiology to another clinical department, it will be 
viewed using a display with different hardware, software, or calibration from how it was 
originally viewed and interpreted. This could have a large effect on how an observer visualizes 
the medical image.  
 
A visual contrast sensitivity experiment was designed to measure the observer threshold for a 
modulating bar pattern under varying background luminance and ambient room illumination 
using two different displays. In addition, the luminance response of each display was measured 
for performance comparison and characterization. The high-performance display exhibited a near 
constant detectability range across different background luminance and ambient room 
illumination while achieving a wider detectability range than the conventional display. The 
conventional display performed the best under dark room illumination but with varying response 
to changes in background luminance. Furthermore, the luminance response of the conventional 
display showed a large deviation from DICOM GSDF part 14 calibration, which contributed to 
the detectability variation. The high-performance display on the other hand exhibited no 
deviation from DICOM GSDF part 14 and appeared to be correctly calibrated.  
 
The following experiments tested the perceptual image quality of medical images using the same 
two displays in a clinical radiation oncology workflow. These experiments were design to 
measure observers’ image quality preference in treatment planning, treatment delivery and 





The treatment planning experiment had observers view medical images on each display and rate 
them in three image categories on a five-point scale. The observers consistent of two groups: 
physicians that contour the area of disease and dosimetrists that contour the healthy tissue 
volume and construct the treatment plan. Both groups chose the high-performance display as the 
display that provided better perceptual image quality in all three categories. Furthermore, both 
groups indicated that the high-performance display allowed for better visualization of organs at 
risk, tumor volume and the subtle difference between them.  
 
The treatment delivery experiment had observers view medical images on each display and rate 
them in three image categories on a five-point scale. In addition, observers performed patient 
position verification using two sets of medical images that required analysis and fusion. The 
observer group consisted of radiation therapists that positioned the patient, analyzed and fused 
the images, and adjusted the patient’s position prior to each treatment. Again, the observer group 
chose the high-performance display as the display that provided better image quality in all three 
categories. Image analysis and fusion took longer using the conventional display which resulted 
in similar positional corrections. These results indicate that the high-performance display not 
only had better image quality but also a more efficient positional correction analysis.  
 
The special procedures experiment had observers view medical images on each display and rate 
them in three image categories on a five-point scale. Similar to the treatment delivery 
experiment, the observer groups consisted of physicians and dosimetrists. Again, both groups 
preferred the high-performance display in all three image quality categories. They indicated the 
high-performance display offered better visualization of critical organs on both MRI and CT 
image sets, a reduction in distorted artifacts, and easier image fusion.  
 
In this dissertation, the role of a high-performance display in radiation oncology was evaluated. 
The difference in perception between a calibrated and non-calibrated display was discussed. A 
contrast sensitivity experiment was performed to optimize the viewing conditions for each 
display. While the conventional display response fluctuated between viewing conditions, the 
high-performance display remained superiorly consistent.  A perceptual image quality 
experiment was performed between the two displays in different phases of the radiation 
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oncology workflow. Results have shown observer preference for the high-performance display in 
every image quality category in all phases of the workflow. In addition, the high-performance 
display decreases image analysis and fusion time without a compromise in the magnitude of 
positional correction.   
 
5.1 Recommendations  
 
This study has shown that a DICOM calibrated high-performance display has a wider 
detectability range and better perceptual image quality than the conventional display currently 
used in most radiation oncology departments. Due to vendor restrictions and lack of FDA 
approval a high-performance display cannot be used currently to treat human patients. However, 
clinics should use the data from this study to optimize the environment in which medical images 
are viewed and interpreted using a conventional non calibrated display. Clinics should ensure 
that both treatment planning and delivery is done in a dark (50 lux) ambient room illumination to 
maximize the perceptibility of the conventional display.  
 
In addition, the AAPM and ACR should form a task group to further examine the use of 
electronic displays in radiation oncology. The task group should use the display quality 
assurance standards from the previous AAPM TG270 and modify it to the needs of radiation 
oncology. They should require monthly quality assurance of the electronic displays used 
currently. The vendor should work with the FDA to allow DICOM calibration of the electronic 
displays they provide with their linear accelerator or provide the option to upgrade to a high 
performance self-calibrating display.  
 
5.2 Future Work 
 
The perceptual image quality comparison should be repeated with a DICOM GSDF calibrated 
conventional display throughout the radiation oncology workflow and compared with the results 
of this study. A DICOM calibrated conventional display would be an intermediate option for 
clinical departments that cannot upgrade to a high-performance display. The results could further 
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motivate the vendor to apply for FDA approval for the use of a DICOM calibrated display with 
their linear accelerator. 
 
Other areas in the field of radiation oncology could benefit from a high-performance display. 
High dose rate (HDR) brachytherapy uses a radioactive source that is places near the tumor site. 
In such case, treatment planning is done “on the spot” right before delivery. Enhanced tissue and 
tumor visualization could reduce planning time and improve the quality of the treatment.  
 
The most common radiation treatment delivery is with a linear accelerator, which is the method 
used in this dissertation. Other methods of radiation treatment delivery exist, such as CyberKnife 
or GammaKnife. These modalities have different methods of patient setup and positional 
verification that could be optimized using a high-performance display.  
 
Long term evaluation of patient outcome and how they can benefit from clinics using a high-
performance display should also be considered. With regards to treatment planning the use of a 
high-performance display has shown to improve the visibility and detectability of critical organs 
and tumor volumes. It should be examined whether or not it translated to a better treatment plan 
by looking at the consistency of contours (both critical organs and tumor) and treatment margins. 
If over time margins get smaller and the contours remain consistent to would indicate a more 
accurate representation of the actual anatomy and an improved treatment plan. The time it takes 
to fully create a treatment plan could be an interesting factor that could also contribute to the 
efficiency of the workflow. 
 
With regards to the treatment delivery phase, the high-performance display has shown improved 
analysis and fusion time without a compromise in positional accuracy. It should be examined if 
efficient treatment delivery translates to better patient care as they spend less time on the 
treatment table and the department could potentially treat more patients. This can be evaluated 
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6 Appendix A: Display Luminance Response and Contrast sensitivity 
Detailed Results  
 
This appendix contains data from the experiments in Chapter 3. Tables 6.1 to 6.3 contain the 
luminance response data for each electronic display compared with the DICOM GSDF part 14. 
Tables 6.4 to 6.12 contain the visual contrast sensitivity data for each electronic display. Figures 






















0 75.49 1.10  75.49 1.1   
15 112.66 2.33 0.72 116.85 2.52 0.78 -9.39% 
30 149.83 4.25 0.58 157.18 4.72 0.61 -4.25% 
45 187.00 7.01 0.49 197.16 7.94 0.51 -3.66% 
60 224.16 10.86 0.43 236.13 12.37 0.44 -1.29% 
75 261.33 16.09 0.39 273.24 18.11 0.38 3.01% 
90 298.50 23.07 0.36 309.18 25.47 0.34 5.34% 
105 335.67 32.30 0.33 344.12 34.76 0.31 7.41% 
120 372.84 44.34 0.31 379.34 46.8 0.30 6.06% 
135 410.01 59.98 0.30 415.92 62.87 0.29 2.26% 
150 447.18 80.17 0.29 452.15 83.29 0.28 3.02% 
165 484.35 106.12 0.28 487.31 108.49 0.26 5.68% 
180 521.52 139.38 0.27 523.16 141.04 0.26 3.71% 
195 558.69 181.89 0.26 560.06 183.64 0.26 0.84% 
210 595.86 236.12 0.26 595.29 235.14 0.25 5.21% 
225 633.03 305.20 0.26 632.56 304.15 0.26 -0.28% 
240 670.20 393.09 0.25 670.33 393.39 0.26 -1.64% 
255 707.37 504.82 0.25 707.37 504.82 0.25 0.30% 





























0 45.29 0.48  45.29 0.48   
15 75.73 1.11 0.79 72.72 0.95 0.66 16.73% 
30 106.18 2.08 0.61 114.76 2.20 0.79 -29.80% 
45 136.62 3.48 0.50 160.00 4.29 0.64 -27.89% 
60 167.06 5.41 0.43 204.04 7.85 0.59 -35.13% 
75 198.50 7.97 0.38 246.79 12.15 0.43 -12.18% 
90 227.95 11.32 0.35 281.61 19.15 0.45 -28.96% 
105 258.39 15.61 0.32 321.38 28.55 0.39 -23.61% 
120 288.83 21.06 0.30 356.18 40.75 0.35 -18.51% 
135 319.27 27.92 0.28 383.04 49.95 0.20 27.51% 
150 349.72 36.47 0.27 407.81 59.05 0.17 37.19% 
165 380.16 47.11 0.25 438.06 70.25 0.17 31.92% 
180 410.60 60.26 0.25 460.98 86.35 0.21 16.08% 
195 441.04 76.47 0.24 494.31 110.25 0.24 -2.54% 
210 471.48 96.40 0.23 514.28 134.25 0.20 14.84% 
225 501.93 120.83 0.22 531.00 148.25 0.10 55.94% 
240 532.37 150.73 0.22 554.27 163.25 0.10 56.27% 
255 562.81 187.25 0.22 568.74 187.25 0.14 36.63% 





































0 34.62 0.33 
 
45.29 0.48   
15 66.03 0.87 0.90 72.72 1.03 0.73 19.22% 
30 97.44 1.76 0.67 114.76 2.43 0.81 -19.93% 
45 128.85 3.07 0.54 160.00 4.91 0.68 -24.58% 
60 160.27 4.93 0.46 204.04 8.62 0.55 -18.04% 
75 191.27 7.43 0.40 246.79 13.85 0.47 -15.04% 
90 223.09 10.73 0.36 281.61 19.65 0.35 4.74% 
105 254.50 15.01 0.33 321.38 28.45 0.37 -10.04% 
120 285.92 20.48 0.31 356.18 38.55 0.30 2.34% 
135 317.33 27.43 0.29 383.04 48.25 0.22 22.91% 
150 348.74 36.17 0.27 407.81 58.95 0.20 27.37% 
165 380.15 47.11 0.26 438.06 74.75 0.24 10.01% 
180 411.57 60.73 0.25 460.98 89.05 0.17 30.87% 
195 442.98 77.62 0.24 494.31 114.25 0.25 -1.49% 
210 474.39 98.52 0.24 514.28 132.25 0.15 38.46% 
225 505.80 124.31 0.23 531.00 149.25 0.12 47.82% 
240 537.22 156.07 0.23 554.27 176.25 0.17 26.77% 
255 568.63 195.10 0.22 568.74 195.25 0.10 53.98% 



















LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
15 0 15 0.00 0 15 0.00 0 15 0.00 11 4 0.73 
30 0 15 0.00 0 15 0.00 0 15 0.00 14 1 0.93 
45 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
60 0 15 0.00 1 14 0.07 7 8 0.47 15 0 1.00 
75 0 15 0.00 7 8 0.47 14 1 0.93 15 0 1.00 
90 3 12 0.20 12 3 0.80 15 0 1.00 15 0 1.00 
105 11 4 0.73 15 0 1.00 15 0 1.00 15 0 1.00 
120 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
165 11 4 0.73 12 3 0.80 15 0 1.00 15 0 1.00 
180 2 13 0.13 6 9 0.40 15 0 1.00 15 0 1.00 
195 0 15 0.00 0 15 0.00 13 2 0.87 15 0 1.00 
210 0 15 0.00 0 15 0.00 8 7 0.53 15 0 1.00 
225 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
240 0 15 0.00 0 15 0.00 0 15 0.00 8 7 0.53 
255 0 15 0.00 0 15 0.00 0 15 0.00 5 10 0.33 
Table 6.4: Contrast sensitivity data for all observers using the MGD with dark ambient room illumination and target background 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 9 6 0.60 
15 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
30 0 15 0.00 0 15 0.00 6 9 0.40 15 0 1.00 
45 0 15 0.00 0 15 0.00 7 8 0.47 15 0 1.00 
60 0 15 0.00 3 12 0.20 15 0 1.00 15 0 1.00 
75 9 6 0.60 10 5 0.67 15 0 1.00 15 0 1.00 
90 14 1 0.93 15 0 1.00 15 0 1.00 15 0 1.00 
105 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
120 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 12 3 0.80 15 0 1.00 15 0 1.00 15 0 1.00 
165 0 15 0.00 9 6 0.60 15 0 1.00 15 0 1.00 
180 0 15 0.00 0 15 0.00 15 0 1.00 15 0 1.00 
195 0 15 0.00 0 15 0.00 10 5 0.67 15 0 1.00 
210 0 15 0.00 0 15 0.00 7 8 0.47 13 2 0.87 
225 0 15 0.00 0 15 0.00 0 15 0.00 7 8 0.47 
240 0 15 0.00 0 15 0.00 0 15 0.00 4 11 0.27 
255 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
Table 6.5: Contrast sensitivity data for all observers using the MGD with dark ambient room illumination and target background 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
15 0 15 0.00 0 15 0.00 0 15 0.00 7 8 0.47 
30 0 15 0.00 0 15 0.00 3 12 0.20 11 4 0.73 
45 0 15 0.00 0 15 0.00 10 5 0.67 15 0 1.00 
60 0 15 0.00 1 14 0.07 15 0 1.00 15 0 1.00 
75 0 15 0.00 11 4 0.73 15 0 1.00 15 0 1.00 
90 4 11 0.27 15 0 1.00 15 0 1.00 15 0 1.00 
105 13 2 0.87 15 0 1.00 15 0 1.00 15 0 1.00 
120 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
165 11 4 0.73 15 0 1.00 15 0 1.00 15 0 1.00 
180 2 13 0.13 8 7 0.53 13 2 0.87 15 0 1.00 
195 0 15 0.00 1 14 0.07 7 8 0.47 15 0 1.00 
210 0 15 0.00 0 15 0.00 5 10 0.33 13 2 0.87 
225 0 15 0.00 0 15 0.00 0 15 0.00 5 10 0.33 
240 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
255 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
Table 6.6: Contrast sensitivity data for all observers using the MGD with dark ambient room illumination and target background 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 12 3 0.80 
45 0 15 0.00 0 15 0.00 3 12 0.20 15 0 1.00 
60 0 15 0.00 0 15 0.00 13 2 0.87 15 0 1.00 
75 0 15 0.00 1 14 0.07 15 0 1.00 15 0 1.00 
90 0 15 0.00 10 5 0.67 15 0 1.00 15 0 1.00 
105 5 10 0.33 15 0 1.00 15 0 1.00 15 0 1.00 
120 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
165 3 12 0.20 10 5 0.67 15 0 1.00 15 0 1.00 
180 0 15 0.00 0 15 0.00 15 0 1.00 15 0 1.00 
195 0 15 0.00 0 15 0.00 11 4 0.73 14 1 0.93 
210 0 15 0.00 0 15 0.00 0 15 0.00 7 8 0.47 
225 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
Table 6.7: Contrast sensitivity data for all observers using the MGD with dim ambient room illumination and target background 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 4 11 0.27 
30 0 15 0.00 0 15 0.00 0 15 0.00 9 6 0.60 
45 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
60 0 15 0.00 0 15 0.00 6 9 0.40 15 0 1.00 
75 0 15 0.00 3 12 0.20 15 0 1.00 15 0 1.00 
90 0 15 0.00 11 4 0.73 15 0 1.00 15 0 1.00 
105 1 14 0.07 15 0 1.00 15 0 1.00 15 0 1.00 
120 14 1 0.93 15 0 1.00 15 0 1.00 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 11 4 0.73 15 0 1.00 15 0 1.00 15 0 1.00 
165 1 14 0.07 11 4 0.73 15 0 1.00 15 0 1.00 
180 0 15 0.00 3 12 0.20 10 5 0.67 15 0 1.00 
195 0 15 0.00 0 15 0.00 6 9 0.40 15 0 1.00 
210 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
225 0 15 0.00 0 15 0.00 0 15 0.00 5 10 0.33 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
Table 6.8: Contrast sensitivity data for all observers using the MGD with dim ambient room illumination and target background 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 7 8 0.47 
45 0 15 0.00 0 15 0.00 4 11 0.27 13 2 0.87 
60 0 15 0.00 0 15 0.00 12 3 0.80 15 0 1.00 
75 0 15 0.00 3 12 0.20 15 0 1.00 15 0 1.00 
90 0 15 0.00 14 1 0.93 15 0 1.00 15 0 1.00 
105 2 13 0.13 15 0 1.00 15 0 1.00 15 0 1.00 
120 12 3 0.80 15 0 1.00 15 0 1.00 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 13 2 0.87 15 0 1.00 15 0 1.00 15 0 1.00 
165 4 11 0.27 11 4 0.73 15 0 1.00 15 0 1.00 
180 0 15 0.00 2 13 0.13 13 2 0.87 15 0 1.00 
195 0 15 0.00 0 15 0.00 5 10 0.33 15 0 1.00 
210 0 15 0.00 0 15 0.00 0 15 0.00 14 1 0.93 
225 0 15 0.00 0 15 0.00 0 15 0.00 6 9 0.40 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
Table 6.9: Contrast sensitivity data for all observers using the MGD with dim ambient room illumination and target background 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
30 0 15 0.00 0 15 0.00 0 15 0.00 9 6 0.60 
45 0 15 0.00 0 15 0.00 1 14 0.07 15 0 1.00 
60 0 15 0.00 5 10 0.33 1 14 0.07 15 0 1.00 
75 0 15 0.00 10 5 0.67 1 14 0.07 15 0 1.00 
90 10 5 0.67 15 0 1.00 4 11 0.27 15 0 1.00 
105 15 0 1.00 15 0 1.00 9 6 0.60 15 0 1.00 
120 15 0 1.00 15 0 1.00 14 1 0.93 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 9 6 0.60 14 1 0.93 15 0 1.00 15 0 1.00 
165 1 14 0.07 2 13 0.13 11 4 0.73 15 0 1.00 
180 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
195 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
210 0 15 0.00 0 15 0.00 0 15 0.00 8 7 0.53 
225 0 15 0.00 0 15 0.00 0 15 0.00 4 11 0.27 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 2 13 0.13 
Table 6.10: Contrast sensitivity data for all observers using the MGD with bright ambient room illumination and target 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 8 7 0.53 
30 0 15 0.00 0 15 0.00 0 15 0.00 11 4 0.73 
45 0 15 0.00 0 15 0.00 1 14 0.07 15 0 1.00 
60 0 15 0.00 6 9 0.40 1 14 0.07 15 0 1.00 
75 0 15 0.00 13 2 0.87 1 14 0.07 15 0 1.00 
90 13 2 0.87 15 0 1.00 4 11 0.27 15 0 1.00 
105 15 0 1.00 15 0 1.00 9 6 0.60 15 0 1.00 
120 15 0 1.00 15 0 1.00 14 1 0.93 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 10 5 0.67 15 0 1.00 11 4 0.73 15 0 1.00 
165 0 15 0.00 9 6 0.60 8 7 0.53 15 0 1.00 
180 0 15 0.00 3 12 0.20 0 15 0.00 15 0 1.00 
195 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
210 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
225 0 15 0.00 0 15 0.00 0 15 0.00 11 4 0.73 
240 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
255 0 15 0.00 0 15 0.00 0 15 0.00 2 13 0.13 
Table 6.11: Contrast sensitivity data for all observers using the MGD with bright ambient room illumination and target 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 8 7 0.53 
30 0 15 0.00 0 15 0.00 0 15 0.00 11 4 0.73 
45 0 15 0.00 1 14 0.07 0 15 0.00 14 1 0.93 
60 0 15 0.00 11 4 0.73 7 8 0.47 14 1 0.93 
75 0 15 0.00 15 0 1.00 13 2 0.87 15 0 1.00 
90 13 2 0.87 15 0 1.00 15 0 1.00 15 0 1.00 
105 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
120 14 1 0.93 15 0 1.00 15 0 1.00 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 8 7 0.53 15 0 1.00 15 0 1.00 15 0 1.00 
165 0 15 0.00 15 0 1.00 15 0 1.00 15 0 1.00 
180 0 15 0.00 6 9 0.40 15 0 1.00 15 0 1.00 
195 0 15 0.00 1 14 0.07 6 9 0.40 15 0 1.00 
210 0 15 0.00 0 15 0.00 0 15 0.00 15 0 1.00 
225 0 15 0.00 0 15 0.00 0 15 0.00 11 4 0.73 
240 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
255 0 15 0.00 0 15 0.00 0 15 0.00 2 13 0.13 
Table 6.12: Contrast sensitivity data for all observers using the MGD with bright ambient room illumination and target 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
45 0 15 0.00 0 15 0.00 0 15 0.00 8 7 0.53 
60 0 15 0.00 0 15 0.00 3 12 0.20 13 2 0.87 
75 0 15 0.00 1 14 0.07 6 9 0.40 15 0 1.00 
90 0 15 0.00 6 9 0.40 13 2 0.87 15 0 1.00 
105 0 15 0.00 11 4 0.73 15 0 1.00 15 0 1.00 
120 5 10 0.33 14 1 0.93 15 0 1.00 15 0 1.00 
135 15 0 1.00 15 0 1.00 15 0 1.00 15 0 1.00 
150 9 6 0.60 14 1 0.93 15 0 1.00 15 0 1.00 
165 2 13 0.13 3 12 0.20 13 2 0.87 15 0 1.00 
180 1 14 0.07 1 14 0.07 9 6 0.60 12 3 0.80 
195 1 14 0.07 0 15 0.00 6 9 0.40 7 8 0.47 
210 0 15 0.00 0 15 0.00 1 14 0.07 6 9 0.40 
225 0 15 0.00 0 15 0.00 0 15 0.00 1 14 0.07 
240 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
255 0 15 0.00 0 15 0.00 0 15 0.00 4 11 0.27 
Table 6.13: Contrast sensitivity data for all observers using the COTS with dark ambient room illumination and target 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 1 14 0.07 
45 0 15 0.00 0 15 0.00 0 15 0.00 7 8 0.47 
60 0 15 0.00 1 14 0.07 4 11 0.27 15 0 1.00 
75 0 15 0.00 4 11 0.27 11 4 0.73 15 0 1.00 
90 3 12 0.20 8 7 0.53 15 0 1.00 15 0 1.00 
105 5 10 0.33 15 0 1.00 15 0 1.00 15 0 1.00 
120 11 4 0.73 15 0 1.00 15 0 1.00 15 0 1.00 
135 11 4 0.73 15 0 1.00 15 0 1.00 15 0 1.00 
150 3 12 0.20 8 7 0.53 13 2 0.87 15 0 1.00 
165 0 15 0.00 1 14 0.07 8 7 0.53 15 0 1.00 
180 0 15 0.00 0 15 0.00 1 14 0.07 12 3 0.80 
195 0 15 0.00 0 15 0.00 0 15 0.00 10 5 0.67 
210 0 15 0.00 0 15 0.00 0 15 0.00 6 9 0.40 
225 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
240 0 15 0.00 0 15 0.00 0 15 0.00 1 14 0.07 
255 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
Table 6.14: Contrast sensitivity data for all observers using the COTS with dark ambient room illumination and target 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 2 13 0.13 
45 0 15 0.00 0 15 0.00 0 15 0.00 5 10 0.33 
60 0 15 0.00 0 15 0.00 0 15 0.00 9 6 0.60 
75 0 15 0.00 0 15 0.00 1 14 0.07 15 0 1.00 
90 0 15 0.00 2 13 0.13 7 8 0.47 15 0 1.00 
105 3 12 0.20 7 8 0.47 13 2 0.87 15 0 1.00 
120 6 9 0.40 13 2 0.87 15 0 1.00 15 0 1.00 
135 11 4 0.73 14 1 0.93 15 0 1.00 15 0 1.00 
150 4 11 0.27 12 3 0.80 15 0 1.00 15 0 1.00 
165 1 14 0.07 7 8 0.47 12 3 0.80 15 0 1.00 
180 0 15 0.00 0 15 0.00 6 9 0.40 14 1 0.93 
195 0 15 0.00 0 15 0.00 0 15 0.00 7 8 0.47 
210 0 15 0.00 0 15 0.00 0 15 0.00 5 10 0.33 
225 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 3 12 0.20 
Table 6.15: Contrast sensitivity data for all observers using the COTS with dark ambient room illumination and target 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 1 14 0.07 
45 0 15 0.00 0 15 0.00 1 14 0.07 10 5 0.67 
60 0 15 0.00 0 15 0.00 2 13 0.13 10 5 0.67 
75 0 15 0.00 1 14 0.07 14 1 0.93 14 1 0.93 
90 0 15 0.00 4 11 0.27 15 0 1.00 15 0 1.00 
105 0 15 0.00 11 4 0.73 15 0 1.00 15 0 1.00 
120 9 6 0.60 15 0 1.00 15 0 1.00 15 0 1.00 
135 11 4 0.73 15 0 1.00 15 0 1.00 15 0 1.00 
150 6 9 0.40 10 5 0.67 15 0 1.00 15 0 1.00 
165 0 15 0.00 0 15 0.00 15 0 1.00 15 0 1.00 
180 0 15 0.00 0 15 0.00 10 5 0.67 9 6 0.60 
195 0 15 0.00 0 15 0.00 6 9 0.40 5 10 0.33 
210 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
225 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
Table 6.16: Contrast sensitivity data for all observers using the COTS with dim ambient room illumination and target background 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
45 0 15 0.00 0 15 0.00 0 15 0.00 4 11 0.27 
60 0 15 0.00 0 15 0.00 1 14 0.07 15 0 1.00 
75 0 15 0.00 1 14 0.07 10 5 0.67 15 0 1.00 
90 0 15 0.00 6 9 0.40 12 3 0.80 15 0 1.00 
105 0 15 0.00 13 2 0.87 15 0 1.00 15 0 1.00 
120 6 9 0.40 15 0 1.00 15 0 1.00 15 0 1.00 
135 12 3 0.80 14 1 0.93 15 0 1.00 15 0 1.00 
150 7 8 0.47 10 5 0.67 15 0 1.00 15 0 1.00 
165 0 15 0.00 4 11 0.27 8 7 0.53 10 5 0.67 
180 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
195 0 15 0.00 1 14 0.07 1 14 0.07 0 15 0.00 
210 0 15 0.00 1 14 0.07 1 14 0.07 0 15 0.00 
225 0 15 0.00 0 15 0.00 1 14 0.07 0 15 0.00 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 2 13 0.13 
Table 6.17: Contrast sensitivity data for all observers using the COTS with dim ambient room illumination and target background 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
45 0 15 0.00 0 15 0.00 1 14 0.07 3 12 0.20 
60 0 15 0.00 0 15 0.00 2 13 0.13 11 4 0.73 
75 0 15 0.00 2 13 0.13 8 7 0.53 15 0 1.00 
90 0 15 0.00 6 9 0.40 13 2 0.87 15 0 1.00 
105 0 15 0.00 10 5 0.67 15 0 1.00 15 0 1.00 
120 5 10 0.33 14 1 0.93 15 0 1.00 15 0 1.00 
135 12 3 0.80 15 0 1.00 15 0 1.00 15 0 1.00 
150 4 11 0.27 9 6 0.60 15 0 1.00 15 0 1.00 
165 0 15 0.00 3 12 0.20 9 6 0.60 12 3 0.80 
180 0 15 0.00 0 15 0.00 0 15 0.00 8 7 0.53 
195 0 15 0.00 1 14 0.07 1 14 0.07 0 15 0.00 
210 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
225 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 1 14 0.07 
Table 6.18: Contrast sensitivity data for all observers using the COTS with dim ambient room illumination and target background 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
45 0 15 0.00 0 15 0.00 1 14 0.07 0 15 0.00 
60 1 14 0.07 1 14 0.07 1 14 0.07 0 15 0.00 
75 1 14 0.07 1 14 0.07 1 14 0.07 7 8 0.47 
90 1 14 0.07 2 13 0.13 4 11 0.27 13 2 0.87 
105 7 8 0.47 9 6 0.60 9 6 0.60 15 0 1.00 
120 12 3 0.80 15 0 1.00 14 1 0.93 15 0 1.00 
135 7 8 0.47 13 2 0.87 15 0 1.00 15 0 1.00 
150 2 13 0.13 9 6 0.60 15 0 1.00 13 2 0.87 
165 1 14 0.07 2 13 0.13 11 4 0.73 12 3 0.80 
180 0 15 0.00 0 15 0.00 0 15 0.00 6 9 0.40 
195 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
210 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
225 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
Table 6.19: Contrast sensitivity data for all observers using the COTS with bright ambient room illumination and target 
























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
45 0 15 0.00 0 15 0.00 1 14 0.07 1 14 0.07 
60 0 15 0.00 1 14 0.07 1 14 0.07 1 14 0.07 
75 1 14 0.07 1 14 0.07 1 14 0.07 4 11 0.27 
90 3 12 0.20 1 14 0.07 4 11 0.27 10 5 0.67 
105 9 6 0.60 8 7 0.53 9 6 0.60 15 0 1.00 
120 15 0 1.00 15 0 1.00 14 1 0.93 15 0 1.00 
135 7 8 0.47 14 1 0.93 15 0 1.00 15 0 1.00 
150 2 13 0.13 9 6 0.60 11 4 0.73 15 0 1.00 
165 1 14 0.07 2 13 0.13 8 7 0.53 13 2 0.87 
180 0 15 0.00 0 15 0.00 0 15 0.00 5 10 0.33 
195 0 15 0.00 0 15 0.00 0 15 0.00 1 14 0.07 
210 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
225 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
Table 6.20: Contrast sensitivity data for all observers using the COTS with bright ambient room illumination and target 

























LP 2 LP 4 LP 6 LP 8 
Yes No P Yes No P Yes No P Yes No P 
0 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
15 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
30 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
45 0 15 0.00 0 15 0.00 1 14 0.07 1 14 0.07 
60 0 15 0.00 0 15 0.00 2 13 0.13 5 10 0.33 
75 0 15 0.00 1 14 0.07 10 5 0.67 13 2 0.87 
90 2 13 0.13 6 9 0.40 14 1 0.93 15 0 1.00 
105 10 5 0.67 13 2 0.87 15 0 1.00 15 0 1.00 
120 13 2 0.87 15 0 1.00 15 0 1.00 15 0 1.00 
135 9 6 0.60 15 0 1.00 15 0 1.00 15 0 1.00 
150 1 14 0.07 11 4 0.73 14 1 0.93 15 0 1.00 
165 0 15 0.00 4 11 0.27 9 6 0.60 15 0 1.00 
180 0 15 0.00 0 15 0.00 7 8 0.47 12 3 0.80 
195 0 15 0.00 1 14 0.07 0 15 0.00 6 9 0.40 
210 0 15 0.00 0 15 0.00 0 15 0.00 4 11 0.27 
225 0 15 0.00 0 15 0.00 1 14 0.07 0 15 0.00 
240 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
255 0 15 0.00 0 15 0.00 0 15 0.00 0 15 0.00 
Table 6.21: Contrast sensitivity data for all observers using the COTS with bright ambient room illumination and target 






















7 Appendix B: Treatment Planning Image Quality Comparison Detailed 
Results 
 
This appendix contains all the data from the image comparison experiment described in section 
4.1. Table 7.1contains the total rating choice of the dosimetry group for each image quality 
category according to the following scale: 
1. Display B (COTS) much better than Display A (MGD) 
2. Display B better than Display A 
3. Both are equal 
4. Display A better than display B 
5. Display A much better than display B. 
 
Table 7.2 contains the calculated VGC data points using the choices in table 7.1. Tables 7.3 to 
7.5 contain the calculated data for the VGC curve and table 7.6 contains additional analysis of 
the VGC curve and AUC.  
 
Rank Contrast Sharpness Resolution 
1 9 11 13 
2 11 10 14 
3 18 22 23 
4 49 54 58 
5 113 103 92 
Total 200 200 200 
Table 7.1: The dosimetry observer group’s total image quality rating in all three categories. 
 
Contrast Sharpness Resolution 
COTS MGD COTS MGD COTS MGD 
1.000 1.000 1.000 1.000 1.000 1.000 
0.955 0.435 0.945 0.485 0.985 0.540 
0.900 0.190 0.895 0.215 0.965 0.250 
0.810 0.100 0.785 0.105 0.850 0.135 
0.565 0.045 0.515 0.055 0.460 0.065 
0.000 0.000 0.000 0.000 0.000 0.000 










0.000 0.000 0.000 0.000 
0.005 0.288 0.140 0.485 
0.010 0.378 0.221 0.559 
0.020 0.485 0.332 0.640 
0.030 0.554 0.412 0.690 
0.040 0.605 0.473 0.726 
0.050 0.645 0.523 0.754 
0.060 0.678 0.564 0.777 
0.070 0.706 0.600 0.797 
0.080 0.730 0.630 0.814 
0.090 0.750 0.657 0.829 
0.100 0.769 0.680 0.842 
0.110 0.785 0.701 0.854 
0.120 0.800 0.720 0.865 
0.130 0.813 0.737 0.874 
0.140 0.826 0.752 0.883 
0.150 0.837 0.766 0.892 
0.200 0.880 0.820 0.924 
0.250 0.910 0.858 0.947 
0.300 0.932 0.885 0.963 
0.400 0.961 0.923 0.982 
0.500 0.978 0.948 0.992 
0.600 0.988 0.966 0.997 
0.700 0.995 0.979 0.999 
0.800 0.998 0.988 1.000 
0.900 1.000 0.995 1.000 
0.950 1.000 0.998 1.000 
1.000 1.000 1.000 1.000 













COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.233 0.108 0.414 
0.010 0.316 0.176 0.490 
0.020 0.418 0.275 0.574 
0.030 0.487 0.348 0.627 
0.040 0.539 0.407 0.666 
0.050 0.580 0.456 0.698 
0.060 0.615 0.497 0.723 
0.070 0.645 0.534 0.745 
0.080 0.671 0.565 0.765 
0.090 0.694 0.593 0.782 
0.100 0.715 0.619 0.797 
0.110 0.733 0.641 0.811 
0.120 0.750 0.662 0.824 
0.130 0.765 0.681 0.835 
0.140 0.779 0.698 0.846 
0.150 0.792 0.714 0.855 
0.200 0.843 0.776 0.895 
0.250 0.880 0.821 0.924 
0.300 0.907 0.854 0.944 
0.400 0.945 0.901 0.971 
0.500 0.968 0.933 0.986 
0.600 0.982 0.955 0.994 
0.700 0.991 0.972 0.998 
0.800 0.996 0.984 0.999 
0.900 0.999 0.994 1.000 
0.950 1.000 0.997 1.000 
1.000 1.000 1.000 1.000 














COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.056 0.007 0.230 
0.010 0.120 0.028 0.332 
0.020 0.233 0.087 0.461 
0.030 0.328 0.156 0.548 
0.040 0.409 0.227 0.613 
0.050 0.477 0.295 0.665 
0.060 0.536 0.358 0.707 
0.070 0.587 0.416 0.743 
0.080 0.632 0.470 0.773 
0.090 0.671 0.518 0.799 
0.100 0.705 0.562 0.822 
0.110 0.736 0.601 0.843 
0.120 0.763 0.636 0.860 
0.130 0.787 0.668 0.876 
0.140 0.808 0.697 0.890 
0.150 0.827 0.722 0.902 
0.200 0.897 0.819 0.947 
0.250 0.938 0.878 0.972 
0.300 0.963 0.917 0.986 
0.400 0.987 0.960 0.997 
0.500 0.996 0.981 0.999 
0.600 0.999 0.992 1.000 
0.700 1.000 0.997 1.000 
0.800 1.000 0.999 1.000 
0.900 1.000 1.000 1.000 
0.950 1.000 1.000 1.000 
1.000 1.000 1.000 1.000 













 Contrast Sharpness Resolution 
Accuracy 85.5% 84.0% 85.8% 
Sensitivity 81.0% 78.5% 85.0% 
Specificity 90.0% 89.5% 86.5% 
VGC AUC 0.923 0.904 0.915 
Std. Dev AUC 0.0133 0.0151 0.0151 
AUC Lower Threshold 0.896 0.873 0.886 
AUC Upper Threshold 0.950 0.935 0.944 
Table 7.6: Additional analysis data from the VGC curve for the dosimetry observer group. 
 
Table 7.7 contains the total rating choice of the physician group for each image quality category.  
Table 7.8 contains the calculated VGC data points using the choices in table 7.7. Tables 7.9 to 
7.11 contain the calculated data for the VGC curve and table 7.12 contains additional analysis of 
the VGC curve and AUC.  
 
Rank Contrast Sharpness Resolution 
1 3 4 5 
2 5 4 5 
3 13 10 9 
4 24 21 20 
5 35 41 41 
Total 80 80 80 
Table 7.7: The physician observer group’s total image quality rating in all three categories. 
 
Contrast Sharpness Resolution 
COTS MGD COTS MGD COTS MGD 
1.000 1.000 1.000 1.000 1.000 1.000 
0.963 0.563 0.950 0.488 0.938 0.488 
0.900 0.263 0.900 0.225 0.875 0.238 
0.738 0.100 0.775 0.100 0.763 0.125 
0.438 0.038 0.513 0.050 0.513 0.063 
0.000 0.000 0.000 0.000 0.000 0.000 










COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.221 0.062 0.500 
0.010 0.302 0.114 0.565 
0.020 0.403 0.199 0.637 
0.030 0.471 0.267 0.682 
0.040 0.522 0.324 0.715 
0.050 0.564 0.373 0.741 
0.060 0.600 0.416 0.763 
0.070 0.630 0.454 0.782 
0.080 0.656 0.487 0.799 
0.090 0.680 0.517 0.813 
0.100 0.700 0.544 0.826 
0.110 0.719 0.569 0.838 
0.120 0.736 0.591 0.849 
0.130 0.752 0.612 0.859 
0.140 0.766 0.631 0.869 
0.150 0.780 0.648 0.877 
0.200 0.833 0.719 0.912 
0.250 0.871 0.769 0.937 
0.300 0.900 0.808 0.955 
0.400 0.940 0.862 0.978 
0.500 0.965 0.900 0.990 
0.600 0.980 0.928 0.996 
0.700 0.990 0.950 0.999 
0.800 0.996 0.968 1.000 
0.900 0.999 0.984 1.000 
0.950 1.000 0.991 1.000 
1.000 1.000 1.000 1.000 













COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.241 0.066 0.539 
0.010 0.325 0.122 0.602 
0.020 0.429 0.213 0.669 
0.030 0.497 0.285 0.710 
0.040 0.549 0.345 0.741 
0.050 0.591 0.395 0.765 
0.060 0.625 0.439 0.785 
0.070 0.655 0.478 0.803 
0.080 0.680 0.512 0.818 
0.090 0.703 0.542 0.832 
0.100 0.723 0.569 0.844 
0.110 0.741 0.594 0.855 
0.120 0.758 0.616 0.865 
0.130 0.773 0.636 0.874 
0.140 0.786 0.655 0.883 
0.150 0.799 0.672 0.891 
0.200 0.849 0.739 0.923 
0.250 0.885 0.786 0.946 
0.300 0.912 0.822 0.962 
0.400 0.948 0.871 0.983 
0.500 0.970 0.906 0.993 
0.600 0.983 0.931 0.997 
0.700 0.992 0.952 0.999 
0.800 0.997 0.969 1.000 
0.900 0.999 0.984 1.000 
0.950 1.000 0.991 1.000 
1.000 1.000 1.000 1.000 














COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.194 0.047 0.483 
0.010 0.270 0.090 0.545 
0.020 0.367 0.166 0.615 
0.030 0.434 0.229 0.659 
0.040 0.485 0.284 0.691 
0.050 0.528 0.332 0.717 
0.060 0.563 0.374 0.739 
0.070 0.594 0.412 0.758 
0.080 0.621 0.446 0.775 
0.090 0.646 0.477 0.790 
0.100 0.667 0.505 0.803 
0.110 0.687 0.531 0.816 
0.120 0.705 0.554 0.827 
0.130 0.722 0.576 0.838 
0.140 0.737 0.596 0.848 
0.150 0.751 0.614 0.857 
0.200 0.809 0.689 0.895 
0.250 0.851 0.743 0.923 
0.300 0.883 0.784 0.945 
0.400 0.928 0.842 0.973 
0.500 0.957 0.883 0.987 
0.600 0.975 0.914 0.995 
0.700 0.987 0.939 0.998 
0.800 0.995 0.960 1.000 
0.900 0.999 0.978 1.000 
0.950 1.000 0.987 1.000 
1.000 1.000 1.000 1.000 
Table 7.11: Physician observer group calculated VGC data for the resolution image quality category. 
 
 Contrast Sharpness Resolution 
Accuracy 81.9% 83.8% 81.9% 
Sensitivity 73.8% 77.5% 76.3% 
Specificity 90.0% 90.0% 87.5% 
VGC AUC 0.899 0.907 0.887 
Std. Dev AUC 0.0246 0.0234 0.0263 
AUC Lower Threshold 0.850 0.860 0.821 
AUC Upper Threshold 0.948 0.954 0.933 
Table 7.12: Additional analysis data from the VGC curve for the physician observer group. 
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This appendix contains all the data from the image comparison experiment described in section 
4.2. Table 8.1contains the total rating choice of the dosimetry group for each image quality 
category according to the following scale: 
1. Display B (COTS) much better than Display A (MGD) 
2. Display B better than Display A 
3. Both are equal 
4. Display A better than display B 
5. Display A much better than display B. 
 
Table 8.2 contains the calculated VGC data points using the choices in table 8.1. Table 8.3 
contains the calculated data for the VGC curve and table 8.4 contains additional analysis of the 
VGC curve and AUC.  
 
Rank Contrast Sharpness Resolution 
1 32 55 46 
2 31 29 52 
3 41 30 27 
4 41 39 35 
5 95 87 80 
Total 240 240 240 
Table 8.1: The therapist observer group’s total image quality rating in all three categories. 
 
Contrast Sharpness Resolution 
COTS MGD COTS MGD COTS MGD 
1.000 1.000 1.000 1.000 1.000 1.000 
0.867 0.604 0.771 0.638 0.808 0.667 
0.738 0.433 0.650 0.475 0.592 0.521 
0.567 0.263 0.525 0.350 0.479 0.408 
0.396 0.133 0.363 0.229 0.333 0.192 
0.000 0.000 0.000 0.000 0.000 0.000 






COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.040 0.012 0.108 
0.010 0.067 0.025 0.150 
0.020 0.110 0.051 0.207 
0.030 0.146 0.077 0.249 
0.040 0.178 0.101 0.284 
0.050 0.207 0.125 0.315 
0.060 0.234 0.148 0.341 
0.070 0.259 0.170 0.366 
0.080 0.282 0.192 0.388 
0.090 0.304 0.213 0.409 
0.100 0.325 0.234 0.429 
0.110 0.345 0.253 0.447 
0.120 0.364 0.273 0.465 
0.130 0.383 0.291 0.482 
0.140 0.401 0.309 0.497 
0.150 0.418 0.327 0.513 
0.200 0.495 0.408 0.582 
0.250 0.561 0.479 0.641 
0.300 0.620 0.542 0.693 
0.400 0.718 0.646 0.781 
0.500 0.796 0.729 0.852 
0.600 0.860 0.798 0.908 
0.700 0.912 0.857 0.949 
0.800 0.953 0.909 0.978 
0.900 0.983 0.955 0.994 
0.950 0.993 0.976 0.999 
1.000 1.000 1.000 1.000 














COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.015 0.003 0.058 
0.010 0.028 0.007 0.084 
0.020 0.050 0.017 0.122 
0.030 0.071 0.028 0.152 
0.040 0.090 0.039 0.177 
0.050 0.108 0.052 0.200 
0.060 0.126 0.064 0.221 
0.070 0.143 0.077 0.240 
0.080 0.160 0.090 0.258 
0.090 0.176 0.103 0.275 
0.100 0.191 0.116 0.291 
0.110 0.207 0.129 0.307 
0.120 0.222 0.143 0.321 
0.130 0.237 0.156 0.336 
0.140 0.251 0.169 0.350 
0.150 0.265 0.183 0.364 
0.200 0.333 0.248 0.427 
0.250 0.396 0.312 0.484 
0.300 0.454 0.372 0.538 
0.400 0.562 0.484 0.638 
0.500 0.659 0.582 0.730 
0.600 0.746 0.669 0.812 
0.700 0.825 0.749 0.884 
0.800 0.894 0.825 0.941 
0.900 0.955 0.901 0.982 
0.950 0.980 0.942 0.994 
1.000 1.000 1.000 1.000 













COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.013 0.003 0.047 
0.010 0.024 0.007 0.070 
0.020 0.044 0.016 0.104 
0.030 0.063 0.026 0.132 
0.040 0.080 0.036 0.156 
0.050 0.097 0.047 0.177 
0.060 0.114 0.059 0.197 
0.070 0.130 0.071 0.216 
0.080 0.145 0.083 0.233 
0.090 0.160 0.095 0.250 
0.100 0.175 0.107 0.266 
0.110 0.190 0.119 0.281 
0.120 0.204 0.132 0.296 
0.130 0.218 0.144 0.310 
0.140 0.232 0.157 0.324 
0.150 0.245 0.169 0.337 
0.200 0.311 0.231 0.400 
0.250 0.372 0.292 0.458 
0.300 0.430 0.350 0.513 
0.400 0.538 0.460 0.614 
0.500 0.636 0.560 0.707 
0.600 0.726 0.650 0.792 
0.700 0.808 0.734 0.868 
0.800 0.883 0.815 0.931 
0.900 0.948 0.896 0.977 
0.950 0.977 0.940 0.993 
1.000 1.000 1.000 1.000 
Table 8.5: Therapist observer group calculated VGC data for the resolution image quality category 
 
 Contrast Sharpness Resolution 
Accuracy 65.2% 58.8% 53.5% 
Sensitivity 56.7% 52.5% 47.9% 
Specificity 73.8% 65.0% 59.2% 
VGC AUC 0.721 0.614 0.597 
Std. Dev AUC 0.024 0.0271 0.027 
AUC Lower Threshold 0.676 0.564 0.547 
AUC Upper Threshold 0.766 0.664 0.647 
Table 8.6: Additional analysis data from the VGC curve for the therapist observer group. 
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9 Appendix D: Special Procedures Image Quality Comparison Detailed 
Results 
 
This appendix contains all the data from the image comparison experiment described in section 
4.3. Table 9.1 contains the total rating choice of the dosimetry group for each image quality 
category according to the following scale: 
1. Display B (COTS) much better than Display A (MGD) 
2. Display B better than Display A 
3. Both are equal 
4. Display A better than display B 
5. Display A much better than display B. 
 
Table 9.2 contains the calculated VGC data points using the choices in table 9.1. Tables 9.3 to 
9.5 contain the calculated data for the VGC curve and table 9.6 contains additional analysis of 
the VGC curve and AUC.  
 
Rank Contrast Sharpness Resolution 
1 10 8 5 
2 7 10 10 
3 14 16 15 
4 20 19 25 
5 24 22 20 
Total 75 75 75 
Table 9.1: The dosimetry observer group’s total image quality rating in all three categories. 
 
Contrast Sharpness Resolution 
COTS MGD COTS MGD COTS MGD 
1.000 1.000 1.000 1.000 1.000 1.000 
0.867 0.680 0.893 0.707 0.933 0.733 
0.773 0.413 0.760 0.453 0.800 0.400 
0.587 0.227 0.547 0.240 0.600 0.200 
0.320 0.133 0.293 0.107 0.267 0.067 
0.000 0.000 0.000 0.000 0.000 0.000 











0.000 0.000 0.000 0.000 
0.005 0.037 0.004 0.175 
0.010 0.063 0.011 0.222 
0.020 0.104 0.026 0.282 
0.030 0.138 0.043 0.324 
0.040 0.169 0.061 0.358 
0.050 0.197 0.079 0.387 
0.060 0.223 0.097 0.412 
0.070 0.248 0.115 0.435 
0.080 0.270 0.133 0.456 
0.090 0.292 0.151 0.475 
0.100 0.313 0.169 0.493 
0.110 0.333 0.187 0.510 
0.120 0.352 0.204 0.525 
0.130 0.370 0.222 0.541 
0.140 0.387 0.238 0.555 
0.150 0.404 0.255 0.569 
0.200 0.481 0.333 0.631 
0.250 0.548 0.404 0.685 
0.300 0.606 0.467 0.733 
0.400 0.706 0.575 0.814 
0.500 0.786 0.662 0.879 
0.600 0.852 0.735 0.929 
0.700 0.906 0.800 0.964 
0.800 0.949 0.859 0.986 
0.900 0.981 0.917 0.997 
0.950 0.993 0.949 0.999 
1.000 1.000 1.000 1.000 












COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.035 0.004 0.159 
0.010 0.059 0.011 0.205 
0.020 0.098 0.026 0.264 
0.030 0.132 0.042 0.306 
0.040 0.162 0.059 0.340 
0.050 0.189 0.076 0.369 
0.060 0.214 0.094 0.395 
0.070 0.238 0.112 0.418 
0.080 0.260 0.129 0.439 
0.090 0.282 0.147 0.459 
0.100 0.302 0.164 0.477 
0.110 0.322 0.181 0.494 
0.120 0.340 0.198 0.510 
0.130 0.358 0.215 0.526 
0.140 0.376 0.231 0.541 
0.150 0.392 0.247 0.555 
0.200 0.469 0.324 0.619 
0.250 0.536 0.393 0.674 
0.300 0.595 0.456 0.722 
0.400 0.695 0.564 0.805 
0.500 0.777 0.653 0.871 
0.600 0.845 0.729 0.923 
0.700 0.901 0.796 0.960 
0.800 0.946 0.857 0.984 
0.900 0.980 0.917 0.997 
0.950 0.992 0.950 0.999 
1.000 1.000 1.000 1.000 














COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.058 0.010 0.209 
0.010 0.093 0.022 0.264 
0.020 0.147 0.048 0.332 
0.030 0.190 0.074 0.380 
0.040 0.227 0.099 0.417 
0.050 0.261 0.124 0.449 
0.060 0.291 0.148 0.476 
0.070 0.318 0.172 0.501 
0.080 0.344 0.194 0.523 
0.090 0.368 0.216 0.544 
0.100 0.390 0.238 0.562 
0.110 0.412 0.258 0.580 
0.120 0.432 0.278 0.597 
0.130 0.451 0.298 0.612 
0.140 0.469 0.317 0.627 
0.150 0.487 0.335 0.641 
0.200 0.564 0.418 0.703 
0.250 0.629 0.489 0.754 
0.300 0.684 0.550 0.798 
0.400 0.774 0.651 0.867 
0.500 0.842 0.730 0.918 
0.600 0.896 0.796 0.954 
0.700 0.937 0.851 0.978 
0.800 0.968 0.900 0.992 
0.900 0.989 0.946 0.999 
0.950 0.996 0.969 1.000 
1.000 1.000 1.000 1.000 













 Contrast Sharpness Resolution 
Accuracy 68.0% 65.3% 70.0% 
Sensitivity 58.7% 54.7% 60.0% 
Specificity 77.3% 76.0% 80.0% 
VGC AUC 0.713 0.705 0.761 
Std. Dev AUC 0.043 0.432 0.039 
AUC Lower Threshold 0.630 0.622 0.684 
AUC Upper Threshold 0.796 0.788 0.838 
Table 9.6: Additional analysis data from the VGC curve for the dosimetry observer group. 
 
Table 9.7 contains the total rating choice of the physician group for each image quality category.  
Table 9.8 contains the calculated VGC data points using the choices in table 9.7. Tables 9.9 to 
9.11 contain the calculated data for the VGC curve and table 9.12 contains additional analysis of 
the VGC curve and AUC.  
 
Rank Contrast Sharpness Resolution 
1 3 2 3 
2 3 4 4 
3 5 6 4 
4 8 6 9 
5 11 12 10 
Total 30 30 30 
Table 9.7: The physician observer group’s total image quality rating in all three categories. 
 
Contrast Sharpness Resolution 
COTS MGD COTS MGD COTS MGD 
1.000 1.000 1.000 1.000 1.000 1.000 
0.900 0.633 0.933 0.600 0.900 0.667 
0.800 0.367 0.800 0.400 0.767 0.367 
0.633 0.200 0.600 0.200 0.633 0.233 
0.367 0.100 0.400 0.067 0.333 0.100 
0.000 0.000 0.000 0.000 0.000 0.000 










COTS MGD Lower Threshold Upper Threshold 
0.000 0.000 0.000 0.000 
0.005 0.064 0.002 0.417 
0.010 0.102 0.007 0.465 
0.020 0.159 0.021 0.520 
0.030 0.205 0.037 0.556 
0.040 0.244 0.055 0.583 
0.050 0.278 0.074 0.606 
0.060 0.309 0.094 0.626 
0.070 0.338 0.114 0.644 
0.080 0.364 0.134 0.659 
0.090 0.388 0.154 0.674 
0.100 0.411 0.174 0.688 
0.110 0.433 0.194 0.700 
0.120 0.453 0.213 0.712 
0.130 0.472 0.232 0.724 
0.140 0.491 0.251 0.734 
0.150 0.508 0.269 0.745 
0.200 0.585 0.353 0.791 
0.250 0.649 0.425 0.830 
0.300 0.703 0.487 0.864 
0.400 0.789 0.586 0.918 
0.500 0.855 0.661 0.955 
0.600 0.905 0.721 0.979 
0.700 0.943 0.774 0.992 
0.800 0.971 0.823 0.998 
0.900 0.990 0.875 1.000 
0.950 0.997 0.908 1.000 
1.000 1.000 1.000 1.000 



















0.000 0.000 0.000 0.000 
0.005 0.079 0.003 0.456 
0.010 0.123 0.010 0.504 
0.020 0.187 0.027 0.558 
0.030 0.237 0.048 0.593 
0.040 0.279 0.070 0.620 
0.050 0.316 0.093 0.643 
0.060 0.348 0.116 0.662 
0.070 0.378 0.139 0.679 
0.080 0.405 0.162 0.694 
0.090 0.430 0.184 0.708 
0.100 0.454 0.206 0.722 
0.110 0.476 0.228 0.734 
0.120 0.496 0.249 0.745 
0.130 0.516 0.269 0.756 
0.140 0.534 0.289 0.767 
0.150 0.551 0.308 0.776 
0.200 0.627 0.394 0.820 
0.250 0.688 0.467 0.857 
0.300 0.739 0.527 0.888 
0.400 0.819 0.621 0.935 
0.500 0.878 0.691 0.967 
0.600 0.922 0.747 0.985 
0.700 0.954 0.795 0.995 
0.800 0.978 0.840 0.999 
0.900 0.993 0.888 1.000 
0.950 0.998 0.917 1.000 
1.000 1.000 1.000 1.000 


















0.000 0.000 0.000 0.000 
0.005 0.052 0.002 0.372 
0.010 0.085 0.006 0.420 
0.020 0.136 0.016 0.476 
0.030 0.177 0.030 0.513 
0.040 0.213 0.045 0.542 
0.050 0.245 0.061 0.566 
0.060 0.274 0.078 0.587 
0.070 0.301 0.095 0.605 
0.080 0.326 0.113 0.622 
0.090 0.349 0.130 0.637 
0.100 0.371 0.148 0.651 
0.110 0.392 0.166 0.664 
0.120 0.412 0.183 0.677 
0.130 0.431 0.201 0.689 
0.140 0.450 0.218 0.700 
0.150 0.467 0.235 0.711 
0.200 0.545 0.315 0.760 
0.250 0.610 0.386 0.802 
0.300 0.666 0.448 0.839 
0.400 0.758 0.551 0.899 
0.500 0.830 0.631 0.942 
0.600 0.886 0.697 0.971 
0.700 0.930 0.754 0.988 
0.800 0.964 0.809 0.997 
0.900 0.987 0.866 1.000 
0.950 0.995 0.902 1.000 
1.000 1.000 1.000 1.000 
Table 9.11: Physician observer group calculated VGC data for the resolution image quality category. 
 
 Contrast Sharpness Resolution 
Accuracy 71.1% 70.0% 70.0% 
Sensitivity 63.3% 60.0% 63.3% 
Specificity 80.0% 80.0% 76.7% 
VGC AUC 0.773 0.795 0.750 
Std. Dev AUC 0.0616 0.0586 0.0641 
AUC Lower Threshold 0.653 0.682 0.625 
AUC Upper Threshold 0.893 0.908 0.875 
Table 9.12: Additional analysis data from the VGC curve for the physician observer group. 
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